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Background: Drug overdose mortality is the leading cause of injury death in both the United 
States (US) and New York City (NYC).  Heroin-related overdoses make up the majority of 
overdoses in NYC.  Since 2006, when a law was passed that allowed for layperson 
administration of naloxone, an opioid antagonist, heroin-related overdose deaths have decreased 
in NYC.  No studies to date have investigated a possible association between the implementation 
of this intervention and heroin-related overdose mortality. 
 
Objectives: To investigate the possible association between overdose prevention programs 
(OPPs) and heroin-related overdose mortality in NYC, using interrupted time series and 
geospatial analytic techniques.   
 
Methods: Using surveillance of NYC accidental drug poisoning deaths (2000-2012), a 
demographic profile of heroin-related overdose deaths was described prior to implementation of 
OPP (January 2000 – June 2006) and after implementation (July 2006 – December 2012).  
Interrupted time series (ITS) analyses tested for a difference in level and trend of heroin-related 
mortality, comparing the post-OPP period with the pre-OPP period, for NYC as a whole.  
Geospatial patterns of heroin-related overdose mortality were described before and after 
v 
implementation of OPP.  After mapping OPP sites, NYC neighborhoods were stratified by 
naloxone penetration level, and using multivariable regression, we tested the hypothesis that 
neighborhoods with greater naloxone penetration experienced steeper declines in heroin-related 
overdose mortality, after controlling for neighborhood characteristics.  We calculated street 
walking distance from the OPP to the location of each overdose fatality in one neighborhood, the 
Lower East Side of Manhattan, to test the hypothesis that risk increases with increasing distance.  
We mapped overdose rate by census tract and conducted Poisson regression. 
 
Results: 2,142 heroin-related overdose deaths occurred in the 6.5 years prior to implementation 
of NYC’s OPP, and 1,764 occurred in the 6.5 years after implementation, representing a 22.4% 
reduction in the age-adjusted mortality rate.  We found, using ITS, that the level of heroin-related 
overdose mortality decreased by 16% (not statistically significantly different from no decrease) 
following implementation.  When analyses were limited to only those parts of NYC with OPP, 
we found that neighborhoods with greatest OPP penetration saw greater decreases in overdose 
mortality rates, compared to neighborhoods without OPPs (-3.1 compared with -0.8). In the 
Lower East Side, we found that census tracts located furthest from the OPP had statistically 
significantly higher overdose mortality rates compared with census tracts closer to the OPP.  The 
census tract where the OPP was located experienced the greatest decrease in heroin-related 
overdose death from pre-OPP to post (from 7.8 to 1.31 per 100,000 population).  An individual is 
1.22 times more likely to die from a heroin overdose for every 1,000 feet away from the OPP 
(p=0.0002).   
 
vi 
Conclusions: While time series analysis of NYC as a whole did not find a statistically significant 
change in the level of heroin-related overdose mortality after implementation of OPP, when OPP 
locations were geocoded, only one-third of NYC neighborhoods had any OPP in the six years 
following implementation.  In analyses limited to those neighborhoods of NYC with OPPs, we 
found statistically significant associations between OPP and heroin-related overdose mortality 
risk.  This suggests that OPP may be contributing to decreased heroin-related overdose mortality 
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Chapter 1: Introduction 
 
1.1.  Overdose Mortality in the United States and New York City 
1.1.1.  Overdose Mortality in the United States 
Drug overdose is an important contributor to morbidity and mortality in the United States (US).  
Since 1990, rates of drug overdose death have more than tripled.
1
  It is now the leading cause of 
injury death in the US, killing more people each year than motor vehicle traffic crashes.
2
  While 
rates of opioid analgesic-related overdose mortality are nearly double that of heroin-related 
overdose mortality (5.1 per 100,000 opioid analgesic-related deaths in 2013, compared to 2.7 per 
100,000 heroin-related deaths), recent years have seen an increase in the rate of heroin-related 
overdose deaths, while opioid analgesic mortality has levelled.  Rates of heroin-related overdose 
mortality has nearly quadrupled since 2000, and most of that increase occurred since 2010.
3
 
Males and non-Hispanic whites aged 18-44 had the highest heroin-related overdose mortality 
rates.  Additionally, nonfatal drug overdose results in a large number of emergency department 
visits each year.  About 830,000 emergency department visits annually are due to drug 




1.1.2.  Overdose Mortality in New York City 
Rates of heroin-related overdose (OD) death are higher in the Northeast of the US compared 
with southern and western parts of the US,
3
 and New York City (NYC) is an extreme example, 
where drug overdose is now the third leading cause of premature death.
5
  The Northeast reported 
3.9 heroin-related overdose deaths per 100,000 in 2013 (a three-fold increase since 2007), while 




after four years of consecutive decreases.
6
  Unlike other places, NYC experiences more ODs 
involving heroin, which is involved in 54% of all fatal ODs, than opioid analgesics, which are 
involved in 27%.  Consistent with national trends, non-Hispanic white New Yorkers, males, and 
individuals aged 15-34 reported the highest rates of heroin-related overdose mortality.  Fatal 
ODs represent the tip of the iceberg; non-fatal overdoses result in approximately 47,000 




1.1.3.  Opioid Overdose Risk 
More than one hundred observational studies have been published exploring fatal and nonfatal 
opioid overdose risk, most employing cohort designs, mortality record review, or cross-sectional 
survey analysis.  More than 20 risk factors have been studied, including sociodemographic 
characteristics (age, gender, race, socioeconomic status (SES)), comorbidities (HIV, HCV, 
mental illness), indicators of risk-taking behavior (criminal justice involvement, sexual risk-
taking, polydrug use, history of previous overdose), and neighborhood effects (drug availability, 
police activity, neighborhood SES). Though no systematic review has been performed, the 
following factors emerge to suggest an association with opioid overdose risk: periods of 
abstinence, including incarceration
8-12
 and drug treatment,
13-15
 followed by a return to use; lack 




 use of benzodiazepines 






 and HCV infection;
12,22
 history of prior 
overdose;
18,24,26
 and availability and use of opioids.
27
   
 





 health-related quality of life;
21
 and sexual risk-taking.
21,22




1.1.4.  Evidence-based Interventions to Reduce Opioid Overdose 
While recent studies have begun to assess the relationship between overdose risk and population-
level interventions, such as prescription drug monitoring programs,
29-31
 most studies to date have 
only assessed the effectiveness of individual-level programmatic interventions geared towards 
reducing opioid overdose risk.  These primary prevention interventions, which are designed to 
“delay or prevent either the initiation of drug use or the probability of progressing from 
experimentation to regular use,” can be contrasted with secondary prevention interventions, 
which aim to “reduce drug use and/or its consequences among experienced drug users.”
32
 
Secondary prevention interventions that aim to reduce opioid overdose risk include psychosocial, 
behavioral, and educational interventions. Medication-assisted interventions are those which 
provide naloxone hydrochloride to individuals at risk of opioid overdose and their social 
networks. 
 
1.2.  Overdose Prevention Programs 
Overdose prevention programs are community-based programs that target individuals at risk of 
opioid overdose and their social networks.
33-35
  The first was in 1996.
34
  Curricula typically 
include recognizing overdose, preventing overdose, discussing risk factors for overdose, teaching 
the appropriate response to overdose, and explaining how to administer naloxone.
36
  These 
programs prescribe and dispense two doses of naloxone in an “overdose rescue kit” for use at a 
future overdose as a first-aid response to opioid overdose in the community setting.  Trainings 
last from 10 minutes to one hour and are located in a variety of settings, including syringe access 
programs, drug treatment programs and other community-based organizations (CBOs), as well as 




health educators or other CBO staff, and naloxone is prescribed and dispensed by a physician 
assistant, nurse practitioner, or medical doctor.
37
  Nearly 200 such programs around the US are 
operational, and since 1996 they have dispensed naloxone to over 53,000 individuals and 
reported over 10,000 reversals.
34
   
 
There are no meta-analyses of OPP studies, though one systematic review of 19 studies was 
recently published.
36
  The review was unable to determine the overall effectiveness of OPPs, 
however, and reported that the overall quality of the studies was fair, with substantial 
methodological problems.
36
  Follow-up was infrequent, and often only among those who 
returned for clinical services.  Study periods were often short, and sample sizes were small.  No 
studies used randomized designs.  The review did find, however, that participation in OPPs was 
associated with overdose reversals, as well as with increased knowledge and ability to respond to 
an opioid overdose and to administer naloxone.   
 
Only one study to date has assessed the relationship between OPPs and overdose mortality at the 
population level.  This study used interrupted time series (ITS) and found that, in Massachusetts, 
communities that had implemented OPPs had lower rates of overdose death compared to 
communities without OPPs.
38
  (One other study has been published that suggests population-
level changes; however, no outside factors were controlled for and detailed analysis was 
provided).
39







1.3.  Gaps in the Current Literature 
While studies suggest that OPPs improve individuals’ knowledge of overdose risk and their 
ability to respond to an overdose, there is a lack of systematic testing of the effectiveness of the 
intervention.  The recently published systematic review (described above) reported that “well-
designed studies are needed to evaluate the extent to which [OPPs] reduce drug-related 




The one study assessing the relationship between OPPs and overdose mortality at the population 
level was an interrupted time series analysis that suggested that OPPs in Massachusetts are 
associated with reduced opioid overdose mortality rates.
38
  The evidence of these benefits of 
OPPs would be strengthened if studies found similar evidence in other settings as well.  We 
believe replication of these findings in NYC would be particularly interesting because of the 
differences between Massachusetts and NYC.  For example, the laws and regulations that allow 
for prescription of naloxone to trained laypersons are different, and allow for standing orders and 
non-clinical dispensing of naloxone in Massachusetts, while in New York until 2014, naloxone 
could only be prescribed by medical doctors, physician assistants, and nurse practitioners, 
making access less widely available.  The Massachusetts study evaluated the effects of naloxone 
across 19 communities, many of which are less urban, less densely populated, and have a lower 
prevalence of injection drug use than NYC.  A study specific to NYC would be of value to 
ascertain the effectiveness of naloxone in an urban center where naloxone may be less widely 





In NYC, heroin-related overdose deaths decreased steadily each year following the 
implementation of the OPP, in 2006, until 2010.  No studies have determined the cause of this 
decrease though a number of outside factors could possibly explain the declining rates:  
decreased rates of heroin use, particularly if there was a shift to opioid analgesic use; increased 
access to and utilization of medication-assisted therapy such as methadone and buprenorphine; 
decreased prevalence of loss of tolerance due to incarceration or detoxification; decreased 
prevalence of polydrug use, such as benzodiazepine or alcohol use with heroin.  Several changes 
occurred in NYC while overdose prevention was implemented.  A timeline of key policy events 
during the study period that could have influenced overdose mortality is found in Appendix I.   
 
I hypothesize that implementation of NYC’s OPP was causally associated with the decrease in 
heroin-related overdose mortality beginning in 2006.  Employing a population-level analysis of 
the relationship between this intervention and overdose mortality in NYC could help determine 
the intervention’s effectiveness and inform policy, both in NYC and nationally. 
 
1.4.  Overview of the Dissertation 
1.4.1.  Overall Goals 
While small-scale evaluations of NYC’s overdose prevention program have been conducted,
40-42
 
no study has evaluated the population-level effects of the intervention on overdose mortality.  
The proposed dissertation will address this gap by examining the overdose prevention program 





This dissertation repeats the Massachusetts methodology in the NYC context, using interrupted 
time series analysis, to evaluate intervention effects over time.  Then, the dissertation adds a 
novel analysis by employing spatial statistics to describe the program and its effectiveness across 
neighborhoods, hypothesizing that those neighborhoods that experienced more overdose 
prevention programming saw steeper declines in heroin-related mortality after controlling for 
other neighborhood-level differences.  
 
Last, the dissertation zooms in to a specific neighborhood in Manhattan, the Lower East Side 
(LES).  The Lower East Side Harm Reduction Center (LESHRC) has the longest-running 
overdose prevention program in the city, which has been described elsewhere in the literature.
40
  
The LES is home to a population representative of New Yorkers overall; mortality and premature 
mortality rates, proportion of residents by age, living in poverty, foreign-born, White, Hispanic, 
without health insurance, and proportion of people who report fair or poor health, mental illness, 
and serious psychological distress are all similar to that of NYC overall.
43
  The rate of drug-
related deaths and drug-related hospitalizations are also similar to those of NYC as a whole.
43
  
Using a method tested in Vancouver, a spatial analysis will describe risk of overdose mortality as 
a function of distance from a naloxone dispensing site and test the hypothesis that risk of heroin-




This study uses robust toxicology data to isolate the targeted population by looking only at 
heroin-specific mortality.  Data such as these, which are only available by matching death 




this study a more targeted study population, as well as allow for the controlling of other 
substances contributing to the overdose. 
 
Conducting both a time series analysis as well as a geospatial analysis, each controlling for 
confounders that could alternatively explain the decrease in heroin-related overdose mortality 
rate, together can build a case for a causal association between NYC’s opioid overdose 
prevention program and decreased risk for heroin-related overdose mortality.   
 
Evidence of a protective effect could be used to shape policy and direct resources towards OD 
prevention interventions in NYC as well as other cities affected by opioid overdose.  Because 
these programs are some of the most promising interventions to address the growing burden of 
overdose mortality, they may prove a crucial element to reversing the current national mortality 
trends. 
 
1.4.2.  Specific Aims 
Aim 1. Describe the average rate of heroin-related overdose mortality in NYC in the seven years 
preceding the implementation of the NYC overdose prevention program (OPP) (2000- June 
2006) and the six years following the implementation of the OPP (July 2006-2012), and test one 
hypothesis. 
 
A descriptive analysis was conducted to assess the rate of heroin-related overdose deaths at the 





Hypothesis 1. Implementation of the OPP in 2006 reduced the rate of heroin-related 
overdose mortality, after accounting for factors other than the OPP that might explain 
temporal change in overdose mortality, between 2000 and 2012. 
 
To assess the effect of the intervention over time while controlling for other factors, interrupted 
time-series (ITS) analysis was conducted using segmented regression.  The exposure was the 
NYC OPP and the outcome was the number of unintentional drug poisoning deaths involving 
heroin.  The unit of analysis was six-month intervals. 
 
The intervention was evaluated using segmented regression to assess (a) a change in level 
immediately after the intervention is implemented, and (b) a change in slope from the pre-
intervention period to the post-intervention period.
45
 The level and trend of the outcome prior to 
the intervention served as a comparison to the level and trend of the outcome after the 
intervention was implemented.
46
   
 
 
Aim 2.  Describe geospatial patterns of heroin-related overdose mortality before (2000-2006) 
and after (2007-2012) the implementation of OPP, and test two hypotheses. 
 
To analyze the effect of the intervention using spatial statistics, the locations of the outcome 
were geocoded and maps were created to detect visual trends in the spatial distribution of the 




created for two time periods, one aggregating years 2000 to 2006, and a second aggregating 
years 2007 to 2012, to represent the magnitude of overdose mortality within each neighborhood.   
   
Clusters of overdose in space were detected with SaTScan™, a software program, using the 
geocoded locations of heroin-related deaths. SaTScan™ “performs geographical surveillance… 
to detect spatial…disease clusters and [assesses] if they are statistically significant” and tests 
whether overdoses are randomly distributed over space.
47
  Overdose clusters that were 
significantly elevated with respect to all of NYC, as a reference, were mapped.   
 
Hypothesis 2.  The reduction in heroin-related overdose mortality rate between the seven 
years preceding the implementation of the OPP (2000-2006) and the six years following 
its implementation (2007-2012) was greater in NYC neighborhood tabulation areas in 
which the OPP was implemented compared with neighborhood tabulation areas in which 
no OPP was implemented. 
 
Overdose prevention programs were implemented more heavily in some neighborhoods of NYC 
and less heavily or not at all in others.  If all NYC neighborhoods are analyzed as a whole, the 
effects of the intervention will be diluted by those neighborhoods that did not experience the 
intervention.  In order to address this issue, neighborhoods were organized into four strata: no, 
low, medium, and high naloxone penetration, a score compiled by summing naloxone doses 
shipped.  This approach allowed for the detection of a potential dose-response relationship 
between the intervention and its effects.  A similar approach was used in the previously 
mentioned Massachusetts study.
38




In order to control for differences in neighborhoods, multivariable regression was conducted, 
using the following neighborhood-level characteristics: proportion of the neighborhood 
population that identifies as White and non-White, proportion over age 60, proportion female, 
proportion of single-person households, and persons per acre.  A final fitted regression model 
was used to predict heroin-related mortality risk by neighborhood tabulation area. 
 
Hypothesis 3.  Within the neighborhood of an OPP at a community-based organization in 
the Lower East Side of Manhattan, risk of heroin-related overdose death increases with 
increasing distance from a naloxone dispensing site. 
 
The Lower East Side’s OPP piloted the overdose prevention initiative beginning in 2004, prior to 
the passage of the state Opioid Overdose Prevention law.  The program has dispensed 2,478 
doses of naloxone in 2004-2012.  To assess the effect of distance from naloxone dispensing 
locations on heroin-related poisoning risk, the street network distance was measured from 
location of each overdose fatality to LESHRC, where naloxone doses were dispensed.  During 
this time period, LESHRC was the largest distributor of naloxone for the Lower East Side 
neighborhood.  Years 2000-2003 (before the program began dispensing naloxone) and 2004-
2012 (when the program was actively dispensing naloxone) were aggregated, and risk of 
overdose death was estimated by calculating the sum of OD deaths that occurred in each census 
tract by the population of that census tract.  Choropleth maps were produced, and the rate of 






1.4.3.  Organization of the Dissertation 
The dissertation consists of four subsequent chapters.  Chapter 2 (Aim 1, Hypothesis 1) describes 
heroin-related overdose mortality in NYC as a whole in the years prior to OPP implementation 
(January 2000 - June 2006) and the years since OPP implementation (July 2006 – December 
2012).  It then evaluates the intervention temporally, using interrupted time series analysis to 
assess the relationship between the passage of the OPP law in 2006 and the change in level and 
slope of heroin-related overdose mortality in NYC.  Chapter 3 (Aim 2, Hypothesis 2) evaluates 
the intervention spatially by comparing NYC neighborhoods with the intervention to those 
neighborhoods without the intervention.  This chapter employs three geospatial analytic tools:  
mapping, cluster detection, and regression.  Chapter 4 (Aim 2, Hypothesis 3) investigates one 
particular neighborhood in NYC, the Lower East Side, to test the hypothesis that overdose risk is 
a function of distance from the intervention site.  Chapter 5 summarizes the key findings from 
Chapters 2 through 4, discusses overall strengths and limitations, and provides suggestions for 
future research.  It concludes with implications for policy in NYC and nationally. 
 
1.4.4.  Significance of the Dissertation 
New York City is one of a limited number of jurisdictions to dispense naloxone to non-medically 
trained community members at risk of opioid overdose and was one of the first to begin doing so.  
As such, it now has one of the largest and most mature overdose prevention initiatives in the US.  
Increasingly other areas of the United States, both urban and rural, are beginning to experience 
opioid overdose burden and will be exploring interventions to curb this trend.  While NYC is 
unique in many ways, such as its dense population and the scale and history of the drug trade and 




impacted by opioid overdose epidemics.  To date, only one study has evaluated the effects of this 
intervention over time at the population level and took place in Massachusetts.
38
 This study 
would replicate the methods of that study in the NYC context, and add to it by exploring the 
effects of the intervention spatially.  Lessons learned could be used to direct NYC policy and 
resources, as well as those in other cities and states. 
 
1.5.  Study Population and Data Sources 
1.5.1.  Study Population   
Because this is an ecologic study, the study population is the population of New York City from 
2000 to 2012.  The exposure is the overdose prevention intervention.  This intervention includes 
both a short educational component and the dispensation of two doses of naloxone to each 
trained responder, either in an intramuscular or intranasal formulation.  For the purposes of this 
study, the intervention will be quantified by the doses of naloxone dispensed in NYC during the 
study period, from the program’s pilot beginning in 2004 in one neighborhood, its legalization 
and implementation in 2006 to the study end, 2012, the most recent year for which mortality data 
is available.   
 
1.5.2.  Data Sources 
Measures of the overdose prevention program are estimated using a proxy:  the number of 
naloxone doses shipped to each of the NYC overdose prevention programs from the suppliers.  
During the study period, over 55,000 doses of naloxone were shipped in NYC.  Data on 
naloxone doses shipped comes from two administrative datasets at these suppliers:  the New 




Department of Health and Mental Hygiene (DOHMH) Bureau of Alcohol and Drug Use 
Prevention, Care and Treatment.   
 
Overdose mortality data came from an ongoing, surveillance database of unintentional drug 
poisoning deaths comprised of two linked data sources:  death certificates and medical examiner 
records.  This database is housed and the sources are linked at DOHMH.  This dataset is a 
complete record of all unintentional overdose deaths in New York City in 2000-2012.  The NYC 
Office of the Chief Medical Examiner is responsible for investigating all deaths believed to be 
homicides, suicides or accidents; deaths of a suspicious unnatural nature; and deaths not attended 
by a physician.  Drug overdose deaths usually fall within these parameters.  Thus the study 
sample is a near census of the population of overdose decedents in NYC during this time period.  
Detailed toxicological results enabled this study to stratify deaths by drug type, and limit the 
sample to those deaths where heroin was involved.  The dataset has detailed geographic 
information, including the address of the location of where the overdose occurred. This granular-
level data allows for geocoding and exact calculation of distance from location of overdose to 
location of nearest naloxone dispensing location in Hypothesis 3. 
 
To account for differences in neighborhoods as well as co-occurring time trends, a few additional 
data sources were used.  HIV infection rates came from NYC DOHMH surveillance.  Numbers 
of individuals admitted for drug detoxification and numbers of individuals utilizing methadone 
maintenance came from the Office of Alcoholism and Substance Abuse Services, the body 
responsible for licensing drug treatment in New York State.  The number of individuals utilizing 




Concomitant use of alcohol or central nervous system depressants with heroin was approximated 
using NYC DOHMH overdose mortality surveillance data.  Opioid analgesic misuse was also 
approximated using this dataset.  Harm reduction participation was approximated using a state 
reporting system which collects the number of unique individuals accessing syringe exchange in 
NYC. 
 
Heroin use prevalence was estimated by using a proxy measure, the proportion of hospital 
discharges that are opioid-related out of the total number of hospital discharges.  This 
information came from the Statewide Planning and Research Cooperative System (SPARCS), a 
NY statewide data system which all Article 28 facilities are required to report to, and contains 
patient-level data on all hospital discharges as well as International Classification of Diseases 
(ICD)-9 codes.  ZIP codes of patient residence are available from SPARCS.  Additionally, 
neighborhoods were characterized using several neighborhood-level variables available from the 
US Census, including:  proportion of the neighborhood population that identifies as white and 
non-white, proportion over age 60, proportion female, proportion of single-person households, 
and persons per acre. 
 
Information on the underlying NYC population for each neighborhood came from the 2000 and 
2010 US census.  Linear interpolated intercensal population estimates based on census data were 
used for years 2001 – 2009.
48






Chapter 2: Implementation of Opioid Overdose Prevention and Heroin-related Overdose 
Mortality in New York City:  Interrupted Times Series Analysis 
 
2.1.  Introduction 
In the United States, overdose is the leading cause of death from injuries, recently surpassing 
traffic accidents in the number of deaths annually.
1
 New York City (NYC) in particular, 
experiences a substantial overdose mortality burden.  In NYC, “accidental drug poisoning death” 
or overdose is the third leading cause of premature death.
2
  In 2013, accidental overdoses killed 
788 people in NYC, more than traffic accidents.
3
  Over half of NYC drug overdose fatalities 
involved heroin.
4
   
 
In contrast to national trends where overdose mortality rates have steadily increased over the last 
decades,
5
 rates in NYC have mainly decreased in recent years, from a high of 13.3 per 100,000 
in 2006 to a low of 8.2 per 100,000 in 2010 and to 11.6 per 100,000 in 2013.
4
  This trend is 
especially pronounced among overdose deaths involving heroin, which decreased from 6.1 per 





Accidental heroin overdoses can be prevented.  In addition to training individuals who use heroin 
on practices to avoid accidental overdose, an opioid antagonist that reverses the effects of 
opioids, naloxone, is available for layperson administration.  In NYC, since an overdose 
prevention program (OPP) was codified in state law in 2006,
6




have been dispensed to trained community members as a first-aid response to opioid overdose 
(unpublished data, NYC Department of Health and Mental Hygiene).  
 
The OPP initiative draws on the theoretical frameworks of the Health Belief Model
7
 and Social 
Cognitive Theory.
8,9
 Overdose prevention trainings last from ten minutes to three hours and are 
located in a variety of settings, including syringe access programs, drug treatment programs and 
other community-based organizations (CBOs), as well as on street corners where drug users 
congregate.  Individuals are trained using a New York state-standardized curriculum in the risk 
factors for opioid overdose, how to recognize an overdose, and the proper response when 
witnessing an overdose, including calling 911, performing rescue breathing, and administering 
naloxone.  Trainings are usually facilitated by health educators or other CBO staff.  After the 
training, naloxone is prescribed and dispensed by a physician assistant, nurse practitioner, or 
medical doctor in the form of an “overdose rescue kit,” for use by the recipient should they 
witness an overdose in the future.
10
  In New York City, the OPP initiative has primarily targeted 
heroin users and their social networks, and the largest proportion of naloxone has been 
distributed through programs serving these populations (unpublished data, NYC Department of 
Health and Mental Hygiene).  Overdose prevention trainings have been described in more detail 
elsewhere.
11
   
 
While studies of OPPs have demonstrated feasibility and acceptability,
12-16
 increase in overdose 
knowledge and response skills,
17-23
 none to date have shown population-level effects on overdose 
mortality in NYC.  The decrease in heroin-related mortality experienced in NYC since 2006 




associated with other concurrent trends that impacted individuals at risk of overdose during this 
time period.  Perhaps fewer people used heroin, decreasing the pool of individuals at risk for 
heroin-related overdose.   Heroin users may have experienced increased utilization of 
medication-assisted therapy, including buprenorphine and methadone, both shown to be 
protective against opioid overdose.
24-29
 Loss of tolerance is a documented risk factor for 
overdose
30
: perhaps fewer heroin users entered opioid detoxification programs which induces 
loss of tolerance.  The expansion of harm reduction programming and specifically overdose risk 
reduction messaging could have decreased prevalence of both fatal and non-fatal overdose 
among heroin users.   
 
This study aims to test the hypothesis that implementation of NYC’s OPP was causally 
associated with the decrease in rate of heroin-related overdose mortality.  Using interrupted time 
series analysis with segmented negative binomial regression models, we will be able to describe 
the effect of the overdose prevention program on heroin-related mortality over time.   
 
2.2.  Methods 
2.2.1.  Study Design 
Observational data from NYC’s overdose surveillance records were analyzed to determine the 
effect of NYC’s OPP on heroin-related mortality using interrupted time series (ITS) analysis 
with segmented negative binomial regression models.  ITS designs are frequently used when an 
intervention was applied at a clear point in time, and several data points were collected on the 
outcome of interest both before and after the intervention was implemented.  When 




quasi-experimental design to evaluate longitudinal effects of…time-delimited interventions.”
31
  
In ITS, the level and trend of the outcome prior to the intervention can serve as a comparison to 
the level and trend of the outcome after the intervention was implemented.
31
  Studies have found 
that ITS using pre-intervention data as controls found comparable average effect measures to that 
of a cluster-randomized controlled trial.
32,33
   
 
In this study, we used an ITS design with segmented negative binomial regression models to 
compare levels and trends of heroin-related overdose mortality after implementation of NYC’s 
OPP to levels and trends prior to implementation.   
 
2.2.2.  Data Collection and Measures   
Independent Variable:  The NYC Overdose Prevention Program 
OPP was treated as a dummy variable, with zero representing the phase prior to passage of New 
York State’s OPP law (Jan 1, 2000 – June 30, 2006) and one representing the phase after (July 1, 
2006 – December 31, 2012). While the OPP initiative rolled out slowly and increased 
incrementally after 2006, this changepoint ensured the earliest possible implementation was 
included for the most conservative estimate of effect.  Effect estimates were similar when the 
changepoint was moved six months and one year forward. 
 
Dependent Variables: Unintentional Heroin-related and Opioid Analgesic-related Overdose 
Deaths 
Outcome data from a NYC Department of Health and Mental Hygiene (DOHMH) surveillance 




December 31, 2012, and comprised of two linked data sources:  death certificates and medical 
examiner records.  The outcome of interest, unintentional drug poisoning death, is defined where 
the death certificate recorded (i) the manner of death as “accidental;” and (ii) the codes for 
underlying causes of death as “poisoning by a psychoactive substance (excluding alcohol or 
tobacco)” (ICD-10 codes X40-X44) or a “mental or behavioral disorder due to a psychoactive 
substance” (ICD-10 codes F11-16, F18-19).  Overdose fatalities with a manner of death listed as 
homicide, intentional, or undetermined were excluded. 
 
OPPs have predominantly been located within agencies that serve heroin users, such as syringe 
exchange programs.  The outcome of interest is overdose fatality with toxicology results positive 
for heroin in order to focus on those individuals who would have been targeted by OPP 
(decedents may have positive toxicology for other drugs as well).  Drugs and drug metabolites 
are abstracted from toxicology reports of medical examiner files, and include alcohol, 
benzodiazepines, cocaine, methadone, heroin, and opioid analgesics.  To test for effects due to 
unmeasured confounders, unintentional overdose fatalities with toxicology positive for opioid 
analgesics were considered as a negative control outcome.  The sample excludes non-NYC 




Drug detoxification, resulting in decreased tolerance, is a documented risk factor for opioid 
overdose.
30,34-36
  The annual number of unique NYC residents discharged from drug 




programs, the NYS Office of Alcoholism and Substance Abuse Services, was used to estimate 
the number of individuals discharged semiannually.  Three types of detoxification services - 
medically monitored withdrawal, supervised inpatient withdrawal, and medically managed 
detoxification - were combined into a summary detoxification variable. 
 
A protective effect on overdose mortality could have been introduced by syringe exchange 
programs, which provide heroin users with overdose prevention education.  The number of 
individuals who received such education was estimated by summing the number of unique 
individuals who received services in NYC syringe exchange programs for each six-month period, 
using a database managed by the state agency responsible for regulating syringe exchange, the 
NYS Department of Health - AIDS Institute. These data were unavailable for the first five six-
month intervals of the study period; missing values were imputed using the linear trend at point. 
 
Because changes in heroin-related overdose mortality could reflect changes in the background 
prevalence of heroin use, we adjusted for this by using a proxy, the number of individuals 
discharged from NYC hospitals for opioid-related diagnoses, excluding detoxification and drug 
rehabilitation discharges.  This data is collected by the NY Statewide Planning and Research 
Cooperative System, a comprehensive data system which collects information on discharges 
from all NYS hospitals. The number of unique individuals discharged from NYC hospitals was 
summed for each six-month period. 
 
A total of 26 time periods from January 1, 2000 to December 31, 2012 (13 periods each in the 




2.2.3.  Procedures and Statistical Analysis 
Age-adjusted mortality rates were calculated for the pre- and post-implementation phases using 
NYC DOHMH population estimates, modified from US Census Bureau intercensal population 
estimates 2000-2012.  A rate difference and a percentage change were calculated to compare 
heroin-related overdose mortality pre- and post-implementation of the OPP.   
 
For interrupted time series analysis, segmented negative binomial regression was used.  Six-
month periods were the smallest time period for which covariate data was available.  The 
outcome was the number of heroin deaths per period.  Cases of overdose deaths were sorted 
based on date of death, and a sum of the number of cases was calculated for each six-month 
period. Linear trends over the study period were accounted for by using a time variable, 
increasing in integer increments for each period.  The changepoint, introduction of OPP, was 
accounted for by using a dummy variable, expressed as zero for each six-month period from 
January 1, 2000 through June 30, 2006, and as one for each six-month period from July 1, 2006 
through December 31, 2012.  A third variable accounted for change in trend after 
implementation of OPP, and allows for estimation of the rate of change in average number of 
overdose deaths per six-month period after implementation of OPP, with all periods prior to 
implementation coded as zero, and periods after implementation starting with one for the first 
period (July 1 - December 31, 2006) and increasing in integer increments for each period after.   
(See Appendix II for model specifications.)   
 
Both visual inspection of time series plots and the literature suggested no seasonal variation in 






The interpolated annual NYC population at risk (defined as individuals ages 15-85) was included 
as an offset term.  Residual autocorrelation and white noise tests performed on the outcome 
variable determined first order autoregressive covariance structure was needed to account for 
correlation between repeated measures.  A negative binomial distribution was used to account for 
excess dispersion.  Negative binomial segmented regression models were estimated using the 
GLIMMIX procedure and non-automated backward elimination was performed to identify the 
model with best fit by comparing -2 residual log pseudo-likelihood.   
 
Because the census of NYC heroin-related overdose deaths 2000-2012 was included in analysis 
and cases were not sampled, inferential statistics to detect findings due to random chance in 
sampling was not necessary.  Any change in mortality was interpreted as a true change.  P-values 
are presented, nonetheless, in order to interpret the study findings as a theoretical sample of a 
hypothetically infinite population, and generalize to a larger geographic area (outside of NYC) 
and a broader time period (prior to 2000 and after 2012). 
 
Sensitivity Analyses 
To account for time trends over the study period that may have contributed to changes in 
overdose risk, sensitivity analyses adjusted for covariates.  Covariates were chosen based on the 
overdose risk literature.  All covariates that may have been associated with the outcome and 
exposure were plotted against time and visually inspected.  Because potential confounders in 
segmented regression are limited to those variables that changed at the same time as the 
intervention, covariates were included in analysis if they changed at the time that OPP was 
introduced.
31




The following covariates were not included in sensitivity analysis as they did not change at the 
time that OPP was introduced:  HIV/AIDS prevalence, which increases risk,
38,39
 and medication 
assisted treatment, which decreases risk for opioid OD.
34,40,41
  During this time period, while 
methadone maintenance utilization decreased, buprenorphine utilization increased.  The two 
variables were combined to form an overall medication assisted treatment (MAT) variable.  See 
Appendix III for time plots of these variables. Other variables that were theoretically presumed 
to be associated with the exposure and the outcome were not included in analysis because data 
was unavailable: prevalence of polydrug use, specifically mixing heroin with alcohol or central 
nervous system depressants,
30,37,42,43




Covariates that met confounding criteria were drug detoxification, overdose prevention 
education, and opioid-related hospitalizations, representing a proxy for prevalence of opioid use 
in the population.  They were tested for multicollinearity using variance inflation factors, and 
added to the segmented regression models.   
 
Additional sensitivity analyses were performed to ensure that the model was detecting true 
effects of the interventions by removing outliers from the most parsimonious model, by adding 
lag effects, and by moving the changepoint forward one and two time periods. 
 
Negative Control Outcome 
To determine whether OPP effects were specific to heroin-related overdose or were due to an 
unmeasured spurious factor, the analyses were repeated with opioid analgesic-related overdose 
as a negative control outcome.
46




and other threats to causal inference in observational studies, where randomization is not 
possible.  Because naloxone effectively counteracts overdoses due to opioid analgesics in the 
same manner that it counteracts overdoses due to heroin, it is assumed to be subject to the same 
sources of bias. The OPP in NYC, however, did not target opioid analgesic users; therefore it is 
hypothesized that the OPP had no effect on opioid analgesic-related overdose deaths during the 
study period.  Using opioid analgesic-related overdose as a negative control outcome, we assume 
that the causal pathways to heroin OD and opioid analgesic OD would be identical with the 
exception of the OPP.  If the relationship between the intervention and heroin-related overdose 
deaths were due to an uncontrolled confounder, we would expect the same pattern to be observed 
among opioid analgesic-related overdose deaths.  
 
Analyses were performed using SAS (v9.2). 
 
2.3.  Results 
A total of 3,906 NYC residents died of unintentional heroin-related poisoning deaths during the 
study period.  In the phase prior to implementation of OPP (January 2000 - June 2006), a total of 
2,142 deaths occurred, or an average of 165 deaths per six-month period (age-adjusted mortality 
rate (AAR) 4.9 per 100,000). (See Table 2.1.)  Following implementation of OPP (July 2006 - 
December 2012), a total of 1,764 deaths occurred, or an average of 136 deaths per six-month 
period (AAR 3.8 per 100,000).  A demographic summary of heroin-related overdose decedents 





Results of a saturated segmented regression model with backward elimination showed that the 
term representing the change in trend following implementation of the intervention did not 
significantly contribute to the model. To maximize parsimony and retain statistical power, this 
variable was removed from the model.  Therefore, the slope was not allowed to change from pre-
intervention to post-intervention periods.  This means that the OPP, while it may be associated 
with a change in the level of heroin-related overdose deaths per period, was not statistically 
significantly associated with a change in the rate of decrease in overdose deaths.   
 
The parsimonious unadjusted model (Appendix II) showed that prior to the implementation of 
OPP, in the years 2000-2006, the trend in heroin-related overdose mortality was level (RR=1.00, 
p=0.7592).  Immediately following implementation of the intervention, there was a 16% 
reduction in heroin-related overdose mortality rate (RR 0.84; p=0.2664).  While not statistically 
significant, this suggests that each six-month period following implementation of OPP would see 
on average a 16% lower heroin-related overdose mortality rate compared with the pre-OPP phase 
(Table 2.3). 
 
2.3.1.  Sensitivity Analyses 
Since all covariate combinations were collinear, each covariate was added separately to perform 
three sensitivity analyses (Appendix II for models and Appendix IV for plot of covariates against 
time).  After adjusting for drug detoxification (sensitivity analysis 1), the level of heroin-related 
overdose mortality rates decreased by 13% after implementation of OPP (RR=0.87, p=0.3748).  
Adjusting for OD prevention education (sensitivity analysis 2) resulted in a 15% decrease in the 




After adjusting for opioid-related hospitalizations (sensitivity analysis 3), representing a proxy 
for prevalence of opioid use in the population, the level of heroin-related overdose mortality rate 
decreased by 14% (RR=0.86, p=0.3512) (Table 2.3).   
 
Results did not differ when outliers were removed, when lag periods were introduced, or when 
the changepoint was moved. 
 
2.3.2.  Negative Control Outcome 
When similar models were applied to the negative control outcome, opioid analgesic-related 
overdose deaths, the intervention seemed to have an effect in the opposite direction.  
Implementation of OPP was associated with a 6% increase in opioid analgesic-related mortality 
rate (RR 1.06, p=0.7007) (Table 2.4).  If a decrease in heroin-related overdose was due to 
confounding or other sources of bias, not the OPP, we would expect opioid analgesic-related 
overdose to decrease as well.  The opposite finding suggests that the effects of OPP on heroin-
related overdose death were specific to the OPP intervention and not due to uncontrolled 
confounders.   
 
2.4.  Discussion 
The 6.5 years following implementation of NYC’s OPP saw an average decrease of 29 heroin-
related overdose deaths per six-month period, compared to the 6.5 years preceding 
implementation of the program.  Aggregated age-adjusted mortality rates decreased by 22.4%, 
from 4.9 per 100,000 in the 6.5 years before OPP implementation to 3.8 per 100,000 in the 6.5 




We found, using segmented negative binomial regression, that implementation of NYC’s OPP 
law in 2006 was associated with a 16% reduction in the level of heroin-related overdose 
mortality, though this finding was not statistically significant.  Sensitivity analyses suggest that, 
after adjusting for time-varying covariates, the effect of the intervention weakened, from 15% to 
13%, though all analyses showed non-significant protective findings.   
 
While results were not statistically significant, because this study included the universe of 
heroin-related overdose deaths rather than a sample of cases, significance testing to determine 
the likelihood of a change due to chance is of limited interpretability. Instead, any change in 
mortality in NYC during this time period should be considered a true change, not one occurring 
due to chance.  Inferential statistics presented here may be used, however, when conceptualizing 
NYC during this time period as a sample of a broader population over a larger time period, and 
interpreted to mean that the decreases observed may be due to chance. 
 
When we modeled the negative outcome control, opioid analgesic-related overdose deaths, we 
found non-significant associations in the opposite direction, suggesting that OPP implementation 
was associated with the decrease in heroin-related overdose deaths independent of other co-
occurring time trends.   
 
The results of this study are similar to those found in Massachusetts, where an 18% decrease in 
opioid-related overdose mortality was found in communities with heavily implemented overdose 
prevention interventions.
47
 Unlike the Massachusetts study, our study was unable to stratify by 




included in the analysis.  This may have biased results towards the null, and contributed to the 
statistical non-significance.  Future studies could remove the neighborhoods without OPP and 
evaluate the effect of the intervention in low-implementing and high-implementation 
neighborhoods separately.   
 
This study has several additional limitations.  This study categorized the intervention 
dichotomously, assuming the exposure was homogenous over the post-implementation time 
period. It did not account for increases in the scale-up of the intervention over time.  By placing 
the changepoint at the earliest possible time that the intervention began, immediately after 
passage of the Opioid Overdose Prevention law, we included the early months of the intervention, 
when dissemination was small, which would conservatively bias the results towards the null.  
The intervention was also piloted at a small scale prior to July 2006, which could have resulted 
in misclassification, biasing the findings towards the null.  Future analyses could introduce a 
second changepoint, creating an additional phase, to account for the early growth years of 2004 
to 2007 or 2008, and isolate change in level and trend in heroin-related overdose deaths from the 
early implementation phase to the later implementation phase.   
 
The limited number of observations meant that we may have had insufficient statistical power to 
detect statistically significant findings.  Direct adjustments for some factors associated with 
opioid overdose were not possible due to unavailable data, including re-entry from jail or prison, 
the prevalence of mixing opioids with alcohol or central nervous system depressants, purity of 
the heroin supply, and buprenorphine utilization.  In particular, adjusting for the increase in 




2008, could have contributed to the decrease in heroin-related mortality, as has been shown in 
Baltimore.
48
  Not including this variable could have biased findings away from the null. 
Baltimore, however, had much more robust uptake of buprenorphine (7,500 unique patients by 
2009, compared to 4,000 in NYC), despite a much smaller overall population, and so we would 
expect the effect of buprenorphine on heroin-related overdose in NYC to be smaller.  
Furthermore, because both buprenorphine and methadone act as opioid agonists and confer a 
protective effect on opioid overdose risk, the effect on overdose mortality should not be 
influenced by combining buprenorphine utilization with methadone utilization. Future analysis, 
analyzing the effects of buprenorphine and methadone separately, could test this assumption.   
 
Adjustments for detoxification, HIV/AIDS prevalence, medication assisted treatment, and harm 
reduction education were considered and included where indicated.  Detoxification admissions 
included detoxification for all substances, and were not limited to opioids only.  Therefore, 
trends in opioid-specific detoxifications may have been obscured.  Adjustment for prevalence of 
heroin use was not possible, and so analysis was performed using a proxy, opioid-related 
hospitalizations, which may be imperfect, particularly as opioid analgesic-related 
hospitalizations may have increased, which would bias the estimate away from the null. If heroin 
use prevalence was changing at a consistent rate, however, this would be accounted for in the 
baseline trend variable in the segmented regression model. 
 
It is possible that the use of opioid analgesic overdose as a negative control outcome could have 
been biased toward the null if opioid analgesic users had received the OPP intervention, resulting 




analyses could replicate this study using an alternate negative control outcome such as motor 
vehicle accidents. 
 
This is the first study to demonstrate population-level effects of the overdose prevention program 
in NYC through the use of an interrupted time series design with segmented regression, a 
multivariable method that accounts for secular trends and is one of the strongest quasi-
experimental methods for assessing the longitudinal effects of an intervention at the ecologic 
level.
31,32
  Because this method estimates pre-intervention trends in the outcome, we can 
distinguish between changes in the outcome that are due to the introduction of the changepoint 
and continuing trends over time.  In particular, while we know that heroin-related overdose 
decedents are aging over time and increasingly involving opioid analgesics and benzodiazepines, 
all of which may contribute to increased overdose mortality, these trends are continuous over 
time, not abrupt, and are accounted for in the pre-intervention trend using segmented regression. 
If they were not fully accounted for, i.e. if the rate of change increased in the post-intervention 
phase, the OPPs intervention effects would be greater than estimated.    
 
Using the universe of heroin-related overdose in NYC during over 13 years, this study is also the 
first to demonstrate population-level effects accounting for changes in detoxification, OD 
prevention education at syringe exchange programs, and prevalence of heroin use, as measured 
by opioid-related hospitalization.  A key strength is this study’s ability to limit cases of opioid 
overdose to those with toxicology results positive for heroin, through access to linked death 
certificates and medical examiner records, to more accurately capture the population targeted by 




confounding and other incorrect sources causal inference,
46
 and suggests that the decrease in 
heroin-related overdose deaths was not due to unmeasured confounders. 
 
This study suggests that the passage of New York’s 2006 Opioid Overdose Prevention Program 
law resulted in a decrease in heroin-related overdose mortality in NYC.  The decrease in 
overdose deaths was striking, reducing the rate of heroin-related deaths by more than 22%, 
though effects dissipated somewhat in multivariable segmented regression analysis.  If we 
assume that high-implementing neighborhoods in NYC are similar to high-implementing 
Massachusetts communities, we would infer that the intervention’s effects seen in this study are 
underestimated.  By expanding OPP and creating more high-implementing neighborhoods, we 
may expect to see more lives saved in NYC.  Future research could strengthen this finding by 
evaluating just those neighborhoods targeted by the intervention to assess whether a dose-


















(Jan 2000-Jun 2006) 
Post-intervention 
(Jul 2006-Dec 2012) 
Total number of ODs in NYC 2142 1764 
Average number of ODs per 6-month period 165 136 
Difference in average -29 NA 
Percentage change in counts -17.58% NA 
Age-adjusted OD mortality rate
1
 4.9 3.8 
Rate difference -1.1 NA 
Percentage change in age-adjusted rate -22.4% NA 
1
Rates are calculated using intercensal New York City population denominators updated July 



























Table 2.2.  Unintentional Heroin-related Overdose Deaths, New York City, Pre- (January 2000 - 





Pre-Implementation of Opioid 
Overdose Prevention 




  N % AAR
1





Total 2142 100% 4.9 1764 100% 3.8 -1.1 




    
Male 1716 80% 8.2 1365 77% 6.2 -2.0 
Female 426 20% 1.9 399 23% 1.7 -0.2 




    




    
Black 479 22% 4.5 353 20% 3.2 -1.3 
White 679 32% 5.9 569 32% 4.6 -1.3 
Hispanic 898 42% 5.8 805 46% 5.2 -0.6 
Other 86 4% X 37 2% X X 




    
Age, Years
2




    
15 to 24 116 5% 1.5 95 5% 1.2 -0.3 
25 to 34 348 16% 3.7 336 19% 3.4 -0.3 
35 to 44 775 36% 8.9 416 24% 5.1 -3.8 
45 to 54 700 33% 9.5 606 34% 7.9 -1.6 
55 to 64 168 8% 3.2 285 16% 4.6 1.4 
65 to 84 24 1% 0.5 25 1% 0.4 -0.1 
Missing 11 1% X 1 0% X X 
        




    
Manhattan 501 23% 5.5 322 18% 3.5 -2.0 
Bronx 500 23% 7.3 503 29% 7.0 -0.3 
Brooklyn 657 31% 5.1 496 28% 3.6 -1.5 
Queens 362 17% 2.9 306 17% 2.4 -0.5 
Staten Island 122 6% 4.9 137 8% 5.4 0.5 




    
Borough of overdose   
 
          
Manhattan 526 25% 5.8 315 18% 3.4 -2.4 
Bronx 476 22% 6.9 448 25% 6.2 -0.7 
Brooklyn 640 30% 4.9 477 27% 3.5 -1.4 




Staten Island 104 5% 4.2 119 7% 4.6 0.4 
Other
3
 77 4% X 140 8% X X 




    




    
Manhattan 551 26% 6.1 360 20% 3.9 -2.2 
Bronx 498 23% 7.3 488 28% 6.8 -0.5 
Brooklyn 666 31% 5.1 509 29% 3.7 -1.4 
Queens 323 15% 2.6 280 16% 2.2 -0.4 
Staten Island 104 5% 4.2 127 7% 5.0 0.8 




    
Neighborhood poverty
4




    
Low (<10% below 
poverty) 157 7% 3.1 140 8% 2.7 -0.4 
Medium (10 to <20%) 663 31% 3.4 559 32% 2.8 -0.6 
High (20 to <30%) 428 20% 5.0 350 20% 3.9 -1.1 
Very high (≥30%) 869 41% 8.1 700 40% 6.2 -1.9 
Missing 25 1% X 15 1% X X 




    




    
Methadone 524 24% 1.2 445 25% 1.0 -0.2 
Opioid analgesics 194 9% 0.4 368 21% 0.8 0.4 
Benzodiazepines 445 21% 1.0 681 39% 1.5 0.5 
Alcohol 1093 51% 2.5 776 44% 1.7 -0.8 
 
1
Rates are calculated using intercensal New York City population denominators updated July 2013. Rates are age-
adjusted using New York City population Census 2000, and averaged across years. 
2
Age standardized rates are presented. Unknown age are not included in the percent of total calculation. 
3
Includes locations outside of NYC and decedents with unknown overdose location 
4
Neighborhood poverty (based on UHF) defined as percent of residents with incomes below 100% of the Federal 



















Table 2.3.  Parameter Estimates, Standard Errors and P-values from Segmented Negative 
Binomial (NB) Regression Models Predicting Heroin-related Overdose Mortality in NYC 
  Coefficient RR SE 
t-
statistic P-value 




Heroin-related OD:  Segmented NB regression model
1
 
   
-0.37 
Intercept B0 -1.6779 - 0.0850 -19.74 <.0001   
Baseline trend B1 -0.0031 1.00 0.0099 -0.31 0.7592   
Level change after OPP B2 -0.1691 0.84 0.1484 -1.14 0.2664   
  
     
  
Sensitivity analyses 
     
  





Intercept B0 -0.5151 - 1.8106 -0.28 0.7787   
Baseline trend B1 -0.0119 0.99 0.0169 -0.70 0.4902   
Level change after OPP B2 -0.1413 0.87 0.1559 -0.91 0.3748   
Detoxification B3 -0.0001 1.00 0.0001 -0.64 0.5270   
  
     
  
2. Heroin-related OD: Segmented NB regression model adjusting for OD prevention education
3
 17.46 
Intercept B0 -1.7119 - 0.2762 -6.20 <.0001   
Baseline trend B1 -0.0046 1.00 0.0156 -0.30 0.7707   
Level change after OPP B2 -0.1621 0.85 0.1612 -1.01 0.3254   
OD prevention education B3 0.0000 1.00 0.0001 0.13 0.8979   
  
     
  
3. Heroin-related OD: Segmented NB regression model adjusting for opioid-related hospitalization
4
 15.11 
Intercept B0 -2.5517 - 1.0993 -2.32 0.0299   
Baseline trend B1 -0.0102 0.99 0.0135 -0.76 0.4549   
Level change after OPP B2 -0.1451 0.86 0.1523 -0.95 0.3512   
Opioid-related hospitalization B3 0.0001 1.00 0.0002 0.80 0.4334   
1
 Log(E(Y)) = β0 + β1Time + β2(OPP)i + log(population) 
2
 Log(E(Y)) = β0 + β1Time + β2(OPP)i + β3(Detox)i + log(population) 
3
 Log(E(Y)) = β0 + β1Time + β2(OPP)i + β3(OD prevention education)i + log(population) 
4
 Log(E(Y)) = β0 + β1Time + β2(OPP)i + β3(Hospitalization)i +  log(population) 
 
Abbreviations: 
RR = risk ratio 
SE = standard error 
Neg = negative 
Res = residual 
OPP = overdose prevention program 
OD = overdose 






Table 2.4.  Comparison of Results Using Negative Control Outcome 
  
Coefficient RR SE t-statistic P-value 
a. Heroin-related OD death: Unadjusted segmented NB regression model 
 
  
Intercept B0 -1.6779 0.19 0.0850 -19.74 <.0001 
Baseline trend B1 -0.0031 1.00 0.0099 -0.31 0.7592 
Level change after OPP B2 -0.1691 0.84 0.1484 -1.14 0.2664 
  
    
  
b. Opioid analgesic-related OD death: Unadjusted NB segmented regression model 
 
  
Intercept B0 -3.5235 0.03 0.0978 -36.04 <.0001 
Baseline trend B1 0.04886 1.05 0.0097 5.01 <.0001 





RR = risk ratio 
SE = standard error 
OPP = overdose prevention program 
OD = overdose 


























Figure 2.1. Age-adjusted Rates* of All Drugs, Heroin-related, and Opioid Analgesic-related 
Unintentional Overdose Deaths, New York City, 2000-2012 
 































































































Chapter 3: Spatial Patterns of Heroin-related Overdose, Pre- and Post-Implementation of 
New York City’s Overdose Prevention Program 
 
 
3.1.  Introduction 
In the United States (US), overdose is the leading cause of death from injuries, recently 
surpassing traffic accidents.
1
  New York City (NYC) in particular experiences a substantial 
overdose mortality burden, where, “accidental drug poisoning death” or overdose (OD) is the 
third leading cause of premature death, killing 788 people in 2013.
2,3
 Accidental ODs now kill 




Despite the substantial mortality burden from overdose, in the years after 2006, unintended OD 
mortality rates rose across the US, but decreased in NYC from an age-adjusted rate of 13.1 per 
100,000 population in 2006 to 10.1 per 100,000 in 2012.
4
 However, this trend was limited to 
heroin-related deaths in NYC which decreased from a high of 6.8 per 100,000 population in 
2003 to a low of 3.1 per 100,000 in 2010
4
 (Figure 3.1).  Overdose deaths involving opioid 
analgesics increased both nationally
1
 and in NYC.
3
 While research suggests that the rise in 
opioid analgesic-related OD mortality is due to the increase in opioid analgesic prescribing,
5,6
 no 
studies have determined the cause of NYC’s decrease in heroin-related OD.  It is possible that 
this pattern is at least partially due to NYC’s policies related to OD prevention. 
 
In 2006, New York State passed a law
7
 which made layperson administration of naloxone, an 
opioid antagonist, a legal, first-aid response to opioid OD in community settings.  Since then, 
non-medically trained community members, including drug users and their friends and family 
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members, have received training in OD prevention and two doses of naloxone which come in an 
‘overdose rescue kit.’  These interventions have traditionally been located at programs that 
primarily serve heroin users, such as syringe exchange programs.  Overdose prevention trainings 




Despite the lack of data supporting evidence-based strategies to reduce OD mortality at the 
population level,
9
 recent research indicates that New York State’s new law may have had an 
impact.  For example, research has documented that heroin users are able to recognize opioid OD 
and administer naloxone properly,
10-13
 and program evaluations have described the number of 
naloxone doses dispensed and, to a lesser degree, the number of OD reversals reported within a 
subgroup of the trained population.
8,12,14-23
  One study has shown a negative linear association 
between naloxone and OD mortality at the population level, comparing Massachusetts 
communities with overdose prevention programs to communities without.
24
  However, there has 
been no comprehensive evaluation of the impact of this initiative on heroin-related OD mortality 
in NYC since 2006.  Rigorous exploration of the effect of NYC’s OD prevention initiative on 
OD mortality could greatly contribute to the fields of injury prevention and substance use, 
enabling policy makers and stakeholders to use evidence-based strategies to address the growing 
OD epidemic nationally and in NYC. 
 
This study used observational data to assess changes in geospatial patterns of heroin-related OD 
mortality in NYC from the seven years preceding the implementation of the overdose prevention 
program (2000-2006) to the six years following implementation of the OPP (2007-2012), and to 
compare these changes in neighborhoods that experienced the intervention with neighborhoods 
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that did not experience the intervention.  Three types of analyses were conducted:  exploratory 
mapping to visually inspect the relationship between reductions in OD mortality and naloxone 
distribution; cluster scanning, which identifies neighborhoods at elevated risk; and regression 
modeling to test the association between naloxone dispensing and OD mortality changes, 
controlling for covariates.  By viewing NYC in the years 2007-2012 as a quasi-experiment, in 
which some neighborhoods hosted the OD prevention initiative and others did not, we can test 
the hypothesis that decreases in heroin-related OD were associated with the initiative.   
 
3.2.  Methods 
3.2.1.  Data Collection and Measures   
Unintentional Heroin-related Overdose Deaths 
Data on heroin-related OD came from a NYC surveillance database of unintentional drug 
poisoning deaths comprised of two data sources:  death certificates and medical examiner 
records, which are linked at the NYC Department of Health and Mental Hygiene.  The 
unintentional drug poisoning death case definition was met if (i) the manner of death was 
“accidental;” and (ii) the codes for underlying causes of death included “poisoning by a 
psychoactive substance (excluding alcohol or tobacco)” (ICD-10 codes X40-X44) or a “mental 
or behavioral disorder due to a psychoactive substance” (ICD-10 codes F11-16, F18-19), as 
recorded in the death certificate.   
 
OPPs have predominantly been located within agencies that serve heroin users, such as syringe 
exchange programs.  Individuals who used heroin were assumed to have been targeted by NYC’s 
overdose prevention program (OPP).  Unintentional OD deaths were included in analysis if 
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toxicology results were positive for heroin or its metabolites, either alone or in addition to other 
drugs.  Drugs and drug metabolites were abstracted from toxicology reports of medical examiner 
files and include alcohol, benzodiazepines, cocaine, methadone, heroin, and opioid analgesics.  
The sample excluded non-NYC residents and homicides, intentional, and undetermined manners 
of death.  
 
Unintentional heroin-related OD deaths of NYC residents from January 1, 2000 to December 31, 
2012 were aggregated by neighborhood and by time period.  Pre-implementation of OPP 
included years 2000-2006, post-implementation of OPP included years 2007-2012.  (While the 
OPP law was passed in July 2006, data on the exposure were available beginning in 2007, so the 
post-implementation time period was set at January 2007.)  The dataset included measures for 
the location of OD, location of death, and location of decedent residence.  This analysis used 
location of OD as that was the site where the intervention could have been performed and is the 
most precise data point; had naloxone been available at that location, the fatality could have been 
averted.  
 
The NYC Overdose Prevention Program (OPP) 
Measures of the locations and volume of NYC overdose prevention trainings were 
operationalized using the locations and number of naloxone doses dispensed.  Dispensing 
locations were collected by contacting Program Directors or Clinical Directors at registered 
OPPs that had received naloxone shipments from 2007-2012. Contacts at each program were 
asked to identify site locations where naloxone doses were distributed in that time period and to 
approximate the percentage of distribution for each site. In most cases, records of distribution 
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locations were available to determine exact proportions of distribution (n=38, or 83% of 
programs); in others, a crude estimation by OPP leadership was used (n=5, 11% of programs).  If 
the number of persons trained was provided instead of doses distributed, it was assumed that 
every person received two doses. The proportions determined from this information were applied 
to the total number of doses ordered by each program, which was available from NYC’s two 
suppliers, NYC Department of Health and Mental Hygiene and NY State Department of Health-
AIDS Institute.  If no information from the program was available, all of the doses were assumed 
to be dispensed at the location for which the program registered with the State Department of 
Health, usually the program headquarters (n=3, or 7% of programs).  
 
Geographic Area and Neighborhood Characteristics 
Neighborhoods were defined as neighborhood tabulation areas (NTAs), which are aggregations 
of census tracts with a minimum 15,000 population. This delineation allows a sufficient number 
of neighborhoods for comparisons (NYC has 195 NTAs), while maintaining homogeneity within 
each neighborhood.   
 
Age, race, gender, population density, and proportion of single-person households were 
measured at the neighborhood level and were used to account for differences between 
neighborhoods that may confound the relationship between the exposure and the outcome.  Age 
was operationalized as the percent of the neighborhood population age 60 or over, and was 
included because studies suggest that OD risk decreases after middle age.
1,3,25-27
 While studies 
that assess the relationship between race and OD risk are inconclusive,
25-28
 because 
neighborhood poverty has been found to be associated with overdose
3,29
 and was unavailable at 
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the NTA level, race was included as a proxy for socioeconomic status.  Race was defined as the 
percent of the neighborhood population that identifies as non-Hispanic white.  Men die of heroin 
OD at nearly four times the rate of that for women,
3,28,30
 so gender was included as the percent of 
the neighborhood population female.  Population density and household composition were each 
included based on theory, despite lack of published evidence: because witnesses must be present 
in order to use naloxone, we assume neighborhoods with more dense populations and 
neighborhoods with fewer single-person households are more able to benefit from naloxone 
programs.  Population density was defined as the number of persons per acre. Household 
composition was defined as the percent of individuals who live in single-person households.  
These data were obtained from publicly available data via NYC’s Department of City Planning.
31
   
Data on drug using prevalence or drug-related morbidity were not available at the NTA level. 
 
3.2.2.  Procedures and Statistical Analysis 
Mapping Exposure and Outcome Variables 
Locations of the overdoses and interventions were geocoded using the NYC Department of 
Health and Mental Hygiene’s geoprocessor GeoPortal.  This allowed for geo-visualization of 
patterns and the application of spatial statistical methods for evaluating associations with the 
intervention.  Locations of OD returned a 19% un-match rate.  Un-matched records were 
manually corrected, and those decedents for whom no street address was available for location of 
OD were removed from the analysis (n=344). Locations of interventions returned no un-matches. 
 
Overdose location data were imported to ArcGIS
® 
geographic information software (v10.0), and 
the total number of ODs was summed for each neighborhood tabulation area.  Neighborhoods 
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were assigned an outcome value, the number of heroin-related OD deaths that occurred in that 
area, and mortality rates were calculated using the population over age 18 in each NTA from the 
US Census 2010.  Data were stratified into two periods: pre-intervention (2000-2006) and post-
intervention (2007-2012), and median number and median rate of ODs per NTA were calculated 
for each period. The median number and rate were divided by the number of years in each period.  
Choropleth maps of the outcome were created to visualize the spatial distribution.  
 
Overdose prevention programs were implemented more heavily in some neighborhoods of NYC 
and less heavily or not at all in others, as programs tended to be sited in areas of highest need 
where injection drug users lived or congregated and where drug OD rates were elevated.  If all 
NYC neighborhoods are analyzed as a whole, the effects of the intervention would be diluted by 
those neighborhoods that did not have the intervention.  To address this, naloxone doses were 
summed for each neighborhood and divided by the neighborhood population at risk, defined as 
residents over age 18.  The mean rate and range of doses dispensed per neighborhood population 
were calculated.  Mean number and rate of doses per neighborhood population were divided by 6, 
the number of years over which the doses were dispensed, in order to estimate a naloxone dose 
rate for each neighborhood per year. 
 
Cluster Detection 
Geospatial clusters of ODs were detected using a spatial scan statistic,
32
 as encoded in the 
SaTScan software (v9.3).
33
  This method evaluates many possible clusters, each centered on a 
NTA and varying in size (number of contiguous NTAs), where the maximum cluster size was set 
to 50% of the underlying population.  For each potential cluster with risk that is elevated relative 
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to everywhere in NYC outside of the cluster, the null hypothesis is tested whereby the elevated 
cluster is assumed to have risen from random chance alone.   
 
Unpopulated neighborhoods such as parks, cemeteries and airports (7 neighborhoods total) were 
removed, which resulted in the removal of 22 OD cases (17 in the pre-OPP period and 5 in the 
post-OPP period).   
 
Clusters with elevated risk were then identified and mapped if there was no more than a 10% 




Exposure and outcome variables were plotted and visually inspected for normality.  Rates of 
naloxone doses dispensed by neighborhood population were not normally distributed, so the rate 
of naloxone doses per thousand population plus a constant (1) was log-transformed.  One outlier, 
a neighborhood in midtown Manhattan which housed the state’s overdose prevention technical 
assistance provider and served as a central naloxone warehouse for other programs, was removed 
from analysis.   
 
In order to accommodate a large number of neighborhoods with no overdose prevention 
programs, naloxone was treated as an ordinal variable with four strata.  Neighborhoods with no 
naloxone doses dispensed formed one stratum and the remaining neighborhoods were allocated 
into three strata with an equal number of neighborhoods in order to maximize statistical power 
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and guarantee sufficient observations within each strata: low (<5.1 doses per thousand residents 
or log dose rate <1.8), medium (6.8 to 20.2 doses per thousand residents or log dose rate 2.1-3.1), 
and high naloxone penetration (>21.9 doses per thousand residents, or log dose rate >3.1). This 
approach allows for detection of a dose-response relationship between the intervention and its 




The number of ODs and OD rates were calculated for each naloxone penetration category, and 
rate differences were calculated to compare pre-intervention to post-intervention periods within 
each penetration category.  Analysis of variance was used to compare rate differences between 
each penetration category, with neighborhoods with no naloxone serving as the reference group.  
The null hypothesis was that the mean OD rate difference for each neighborhood penetration 
strata was equal. 
 
The analysis was repeated controlling for neighborhood characteristics using linear regression. 
Neighborhood-level predictor variables included proportion of the population over age 60, 
female, white non-Hispanic, single-person households, and persons per acre.   
 
As a sensitivity analysis, to test for a dose-response association solely among the neighborhoods 
with any naloxone while controlling for key neighborhood characteristics, ordinary least squares 
regression was performed using the log of naloxone doses as a continuous predictor, and the 




All multivariable regression analyses used backward elimination to reject covariables that were 
not significantly associated with the difference in OD mortality rate (t-statistic p>0.05).  Since 
our units of observation, NTAs, are spatially contiguous polygons, the model was tested for 
residual spatial autocorrelation using global Moran’s I statistic. Model residuals were not 
spatially autocorrelated (Moran’s I p=0.8293), so standard multivariable regression was used.  
Regression analyses were performed using SAS (9.2). 
 
3.3.  Results 
In the study period (2000-2012), there were a total of 3,562 unintentional heroin-related OD 
deaths in NYC: 2,182 OD deaths in the years prior to OPP (2000-2006) and 1,380 in the years 
after implementation of OPP (2007-2012).  
 
On average, neighborhoods experienced 1.14 heroin-related OD deaths per year in the years 
prior to implementation of OPP and 1.00 heroin-related OD death per year in the years following 
implementation of OPP (Table 3.1).   
 
3.3.1.  Mapping Exposure and Outcome Variables 
Maps of heroin-related OD by neighborhood are shown in Appendix V. 
 
In the six years immediately following implementation of OPP, a total of 57,097 naloxone doses 
were dispensed in NYC, or an average of 8,157 doses per year, from 152 dispensing locations.  
One-third of NYC neighborhoods (64 NTAs or 34%) hosted at least one naloxone dispensing 
location, with neighborhoods ranging from one to 12 dispensing sites.  The mean number of 
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naloxone doses dispensed over seven years by neighborhood was 300 (range 0 to 6,635), or an 
average of 50 doses per year (Table 3.2). For a map of naloxone doses dispensed by 
neighborhood, see Figure 3.2. 
 
3.3.2.  Cluster Detection 
Spatial scans detected 7 clusters of heroin-related OD prior to OPP, three of which were 
statistically significant (p<0.10).  These clusters were located in the South Bronx/Northern 
Manhattan, Central and Downtown Brooklyn/Lower East Side Manhattan, and East Brooklyn.  
After implementation of OPP, 5 clusters were detected, three of which were statistically 
significant (p<0.10): South Bronx, Lower East Side Manhattan, and Central Brooklyn (Appendix 
VI).  All three clusters shrank in size from pre- to post-OPP, and the northern Manhattan 
neighborhoods, which had substantial naloxone coverage, disappeared from the cluster altogether. 
The cluster relative risk in Central Brooklyn, an area with fairly little naloxone coverage, did not 
change from pre- to post-OPP (RR=1.9, 2.0, respectively). 
 
3.3.3.  Regression Modeling 
Two-thirds of neighborhoods had no naloxone dispensed (n=124).  The remaining 
neighborhoods were stratified into tertiles of 21 neighborhoods each (low, medium, high 
naloxone penetration, each containing 11% of all NYC neighborhoods). 
 
Neighborhood groups experienced mean OD rates between 3.6 and 9.5 per 1,000 population in 
the pre-OPP period and between 2.8 and 6.4 in the post-OPP period (Table 3.3). All four strata 
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saw decreases in OD mortality from pre- to post-OPP, with high penetration neighborhoods 
experiencing the largest rate decrease. 
 
Differences in rate of OD from pre- to post-OPP increased in magnitude with a dose-response 
relationship from low to high naloxone penetration level (-0.7, -1.6, -3.1 ODs per person-year 
per neighborhood), though neighborhoods with no naloxone also experienced a decrease in OD 
mortality which was similar to that experienced by neighborhoods with low naloxone penetration 
(-0.8 OD per person-year per neighborhood).  The difference in rate between high penetration 
neighborhoods and no naloxone neighborhoods was statistically significant (p<0.0001) in an 
unadjusted regression model.   
 
After controlling for neighborhood characteristics (proportion of the population age 60 and over, 
female, white non-Hispanic, population density, and proportion of single-person households), 
only population density remained statistically significant (p=0.0094) and was retained in the 
multivariable model.  The association between high naloxone penetration neighborhoods and no 
naloxone neighborhoods remained significant after controlling for population density (p=0.0007).  
Low and medium naloxone penetration neighborhoods did not experience OD rate changes 
significantly different from neighborhoods with no naloxone (p=0.5106 and p=0.2386, 
respectively). 
 
Sensitivity analysis, limiting the sample to the 63 neighborhoods with any naloxone distribution 
and treating the predictor as a continuous variable, also found that the only statistically 
significant neighborhood covariate was population density (p=0.0027).  All other neighborhood 
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covariates were dropped from the multivariable model.  Naloxone dose rate was statistically 
significantly associated with OD rate difference (p=0.0003), after controlling for population 
density (Table 3.4).  For every increase of 10 doses per 1,000 neighborhood population, the 
expected rate difference is -2.6, after controlling for population density.  See Appendix VII for 
specification of the multivariable models. 
 
3.4.  Discussion 
When comparing decreases in OD mortality from the years prior to NYC’s overdose prevention 
program to the years following its implementation, we detect a statistically significant difference 
between high naloxone penetration neighborhoods and those neighborhoods with no naloxone.  
Neighborhoods that had high naloxone penetration experienced a nearly four-fold decrease in 
OD deaths (3.1 per 100,000 rate difference) over neighborhoods with no naloxone (0.8 per 
100,000).  Medium and low naloxone penetration neighborhoods did not demonstrate changes in 
OD mortality significantly different from neighborhoods without naloxone.  When 
neighborhoods without naloxone were removed from the analysis and the number of naloxone 
doses dispensed per neighborhood population was treated as a continuous variable, a significant 
dose-response relationship was seen between naloxone and change in OD mortality, after 
controlling for neighborhood characteristics. For every 10 doses of naloxone distributed per 
1,000 residents, we would expect to see two to three lives saved. 
 
While we would expect several of the covariates, such as gender, age, and living alone, to be 
significant predictors of OD risk at the individual level, it is not surprising that they are 
insignificant at the neighborhood level because neighborhoods did not demonstrate large 
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variation.  Population density was shown to be significantly associated with OD mortality 
change; more densely populated neighborhoods saw steeper decreases in OD mortality.  We 
suspect that this is because ODs are more likely to be witnessed and responded to in more 
densely populated neighborhoods.  Given the shifting OD epidemic to more wealthy and 
suburban communities that are presumably less densely populated, this finding poses important 
questions for policymakers and program coordinators.  
 
This study’s findings replicate those found in Massachusetts, where a dose-response relationship 
between naloxone implementation and OD mortality was demonstrated at the community level.
24
  
This study builds on the Massachusetts findings by replicating the study in a much more densely-
populated jurisdiction and comparing neighborhoods located closer to each other than the 
communities studied in Massachusetts.  Furthermore, it isolates the population targeted by the 
intervention by solely examining heroin-related OD. 
 
We were surprised to find that OD mortality decreased in neighborhoods with no naloxone 
distribution, though to a smaller degree than neighborhoods with medium and high levels of 
naloxone penetration.  This decrease could be due to a number of unmeasured factors, such as 
decreased prevalence of heroin use or decreased heroin purity, or increased access to substance 
use disorder treatment.  Unfortunately, these measures were not available at the neighborhood 
level. Other drug use trend data were unavailable at the neighborhood level, including age of the 
heroin user and concomitant use of substances such as benzodiazepines and opioid analgesics 
with heroin.  Citywide data, however, suggest an increase in age, concomitant drug use and 
perhaps heroin use prevalence, which would each lead to an increase in overdose mortality, 
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resulting in a conservative estimate of the OPP’s effect.  Similarly, poverty measures were 
unavailable at the neighborhood level.  While race was included as a proxy for poverty, there 
may be residual confounding.  Future analyses could strengthen the findings by incorporating 
drug-using characteristics and poverty measures into neighborhood-level ecologic analyses. 
 
This analysis used location of overdose as its main outcome on the basis that this location is the 
most precise point at which the intervention could have been used to avert overdose mortality.  It 
is possible, however, that if a person lived closer to the OPP, they may have been more likely to 
receive the intervention, even if they are using heroin and at risk of overdose further from the 
program.  In future analyses, the location of residence could be used as the main outcome to 
assess this hypothesis and compare findings to those presented here. 
 
Diffusion of the intervention outside of the neighborhoods in which they were housed may also 
have contributed to the small decreases in OD mortality in the neighborhoods with no naloxone.  
A limitation of this study is that we do not know the degree to which this may have occurred.  
Given the tightly spaced neighborhoods of NYC and its efficient public transportation system 
making it easy to travel from one neighborhood to another, it is possible that individuals received 
naloxone in one neighborhood and used it to prevent OD fatality in another.  We suspect that this 
occurrence, however, is minimal because previous studies have shown that individuals who 
access syringe exchange programs, the majority of OPP participants during the study period, live 
within a ten-minute walk from the program on average,
34
 and the majority of ODs occur in the 
home.
35
  If we assume that diffusion occurred to some degree, the results would bias towards the 
null, underestimating the association between the intervention and OD mortality.  Future 
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analyses could account for the ways in which drugs and drug use move throughout the city 
geospatially, on the assumption that naloxone would move similarly, including subway lines, 
airports and train stations, and gang activity.   
 
This study used the number of doses shipped to each program from the suppliers. We do not 
know how many doses of naloxone were actually dispensed to individuals at each program.  It is 
likely that programs did not dispense all of the naloxone that they were shipped.  Thus, the 
associations found were a conservative estimate, if in fact a smaller number of doses were 
associated with the decrease in OD mortality. 
 
While the exposure is measured as naloxone doses dispensed, in fact individuals receive 
overdose prevention training with naloxone.  Training curriculum includes information on ways 
to reduce risk of opioid OD.  The association found in these analyses must be jointly attributed to 
both the naloxone doses and the educational intervention, since it is not possible to separate the 
effects of the two.  Therefore, we cannot determine which aspect(s) of the intervention is the 
“active ingredient” associated with decreased OD mortality. 
 
Last, all analyses were performed at the ecologic level using observational data.  While evidence 
suggests program effectiveness, we cannot conclude that the relationship between the overdose 
prevention program and overdose mortality is causal.   
 
Given the paucity of evidence-based strategies to reduce overdose mortality at the population 
level, this study contributes important information in favor of public health policies and 
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resources that support community-based overdose prevention programs and naloxone 
distribution among non-medically trained bystanders.  While NYC is unlike other jurisdictions in 
some ways, given that similar results were found in Massachusetts communities, this suggests 
these findings may be generalizable to other settings experiencing similar overdose epidemics.   
 
Overdose mortality rates continue to rise nationally and remain the third largest premature killer 
in NYC.  Because of this substantial burden, providing at-risk individuals with evidence-based 
tools is ever more critical.  Naloxone and overdose prevention education for individuals at-risk 










Total number of ODs 2182 1380 
Years in period 7 6 
Number of ODs/# of years in period 311.7 230.0 
Median number of ODs per NTA (range) 8 (0,53) 6 (0, 34) 
Median number of ODs per NTA/# of years  in period 1.1 1.0 
Median rate of ODs per NTA per 100,000 population 18+ (range) 3.8 (0.0, 18.8) 2.9 (0.0, 12.3) 





NTA = neighborhood tabulation area 
OD = overdose 




Table 3.2.  Naloxone Information by Neighborhood Tabulation Area (NTA), NYC, 2007-2012 
 
Mean Range 
Naloxone doses dispensed per neighborhood 300 min=0, max=6,635 
Naloxone doses dispensed per neighborhood/# of years 50 0, 1106 
Rate of naloxone per neighborhood per 1,000 pop 18+  8.0 0.0, 153.3 
Rate of naloxone per neighborhood per 1,000 pop 18+/# of years 1.3 0.0, 25.6 
 
Abbreviations: 
NTA = neighborhood tabulation area 
Min = minimum 
Max = maximum 


















































































* Low <5.1 doses per thousand residents (log dose rate <1.80); medium = 6.8 to 20.2 doses per thousand residents (log dose rate 2.05-3.06); high naloxone 
penetration >21.9 doses per thousand residents (log dose rate >3.13) 
**Pre-OPP period = Jan 1, 2000 to Dec 31, 2006.  Post-OPP period = Jan 1, 2007 to Dec 31, 2012 




OPP = overdose prevention program 
















Log naloxone dose rate -1.07 0.309 0.0009 -1.12 0.289 0.0003 
Persons per acre -0.01 0.004 0.0027 -0.02 0.007 0.0025 
Proportion of population age 60+ 4.18 3.072 0.175 N/A
** 
- - 
Proportion of population female 2.29 6.939 0.7421 N/A - - 
Proportion of population White non-
Hispanic 
0.57 0.638 0.3747 N/A - - 
Proportion of single-person 
households 
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61 
Figure 3.2. Difference in Heroin-related Overdose Mortality Rate (Post-OPP – Pre-OPP) by 







Chapter 4: Using Spatial Methods to Evaluate Overdose Prevention in the Lower East 
Side, New York City, 2000–2012 
 
4.1.  Introduction 
Overdose deaths in the United States (US) have nearly quadrupled since 2000, and are now the 
country’s largest cause of injury-related death.
1 
 The increase in this epidemic has been seen 
most acutely in recent years, when the rate of heroin-related overdose rose from 1.0 per 100,000 
in 2010 (n=3,036) to 2.7 in 2013 (n=8,257).
1
  New York City (NYC) has experienced a similar 
trend.  Between 2010 and 2013, the rate of heroin-related overdose deaths rose each year, from 




With the burden of heroin-related overdose rapidly increasing, there is a critical need to design, 
implement, and evaluate effective interventions that decrease overdose mortality.  Community-
based overdose prevention education with naloxone distribution is one such intervention that has 
seen increasing popularity in the US.  This intervention, which has been implemented in 27 
states and the District of Columbia, provides training to drug users and their social networks in 
overdose risk factors, recognition of opioid overdose, and appropriate responses, including 
administering naloxone hydrochloride, an opioid antagonist that reverses the effects of an opioid 
overdose.
3
  According to a 2012 Centers for Disease Control report, overdose prevention 
programs (OPPs) have distributed naloxone to over 53,000 individuals and have received reports 
of over 10,100 overdose reversals since 1996.
4





A New York State law passed in July 2006 made layperson administration of naloxone a legal, 
first-aid response to opioid overdose.  Since then, non-medically trained community members in 
NY, including drug users and their friends and family members, can receive training in overdose 
prevention and two doses of naloxone which comes in an ‘overdose rescue kit.’  Overdose 
prevention trainings are provided by community-based organizations that serve drug users, 
facilitated by health educators, nurse practitioners or physician assistants, and typically last from 





Several studies have demonstrated that nonmedical bystanders trained at OPPs can appropriately 
respond to opioid overdose, including administering naloxone.
6-14
 Many of these studies, 
however, lack systematic follow-up methods, rely on self-reported naloxone utilization data only 
from those participants who return to the OPP, and suffer from small sample sizes and short 
follow-up periods.  Despite the proliferation of OPPs in response to the rising epidemic, rigorous 
analyses of the population-level effectiveness of these programs are sparse.  Only one study was 
designed to show population-level effects, and it reported that communities with comprehensive 
OPPs experienced decreases in overdose mortality, compared to communities without OPPs.
15
  
No studies have delineated the geographic boundaries of the area in which these interventions are 
effective, though studies of other harm reduction programs have done so, suggesting the need for 
locally sited interventions.
16-18
  Further studies of community-based overdose prevention 
programs are needed to describe and evaluate the public health impact of OPPs in reducing 
mortality associated with opioid overdose,
19
 and particularly, to determine how interventions 




In order to address this gap, this study aims to examine the public health impact of a community-
based OPP in NYC’s Lower East Side by testing the hypothesis that overdose risk increases with 
distance from the OPP location.  One other study to date has used this method to test intervention 
effects on overdose mortality, by examining mortality risk as a function of distance.
20
  This 
rationale derives from Bradford Hill’s causal criterion of specificity, which states that a causal 




The study will use overdose mortality surveillance data, comparing mortality rates before and 
after the implementation of the OPP, as a more thorough and robust source of information than 
self-reported naloxone utilization data, which is incomplete and subject to selection bias.  
Because the surveillance data is derived from the NYC Office of the Chief Medical Examiner, 
which is responsible for investigating all deaths of a suspicious nature, this data is believed to 
represent the census of all heroin-related overdose deaths in this NYC neighborhood.  A study 
period of 13 years (2000-2012) will allow for a more stable analysis of differences between pre- 
and post-implementation periods, and is less likely to be subject to chance fluctuations in 
overdose rates year to year.
22
   
 
The Lower East Side’s OPP has the longest-running overdose prevention program in the city, 
which began as a pilot in 2004, and has been described elsewhere.
23
  This OPP serves as an 
opportunity to evaluate the community-level effects on an OPP’s surrounding area.   
 
The Lower East Side (LES) neighborhood in NYC is home to a population representative of 




age, living in poverty, foreign-born, White, Hispanic, without health insurance, and proportion of 
people who report fair or poor health, mental illness, and serious psychological distress are 
similar to that of NYC overall.
24
  The rate of drug-related deaths and drug-related 
hospitalizations are also similar to those of NYC as a whole.
24
  This study’s results could be used 
to shape policy and direct responses to opioid overdose in NYC and elsewhere.   
 
4.2.  Methods 
4.2.1.  Data Collection and Measures 
Unintentional Heroin-related Overdose Deaths 
Data were derived from a NYC surveillance database of unintentional opioid poisoning deaths 
from years 2000 to 2012 that comprised of two linked data sources:  death certificates and 
medical examiner records.  The outcome of interest, unintentional drug poisoning death, was 
defined as the death certificate recorded (i) the manner of death as “accidental;” and (ii) the 
codes for underlying causes of death as “poisoning by a psychoactive substance (excluding 
alcohol or tobacco)” (ICD-10 codes X40-X44) or a “mental or behavioral disorder due to a 
psychoactive substance” (ICD-10 codes F11-16, F18-19) (n=6,582).   
 
OPPs have predominantly been located within agencies that serve heroin users, such as syringe 
exchange programs.  Individuals who used heroin were assumed to have been targeted by NYC’s 
overdose prevention program (OPP).  For this study, we limited to heroin-related overdose 
deaths in order to focus on those individuals who could have been targeted by the OPP (n=4,533).  
Toxicology results were derived from medical examiner records, and classified into drug 




deaths that involve alcohol, benzodiazepine, cocaine, heroin, opioid analgesic, and methadone.  
Decedents may have had positive toxicology for other drugs as well.  Cases were excluded if 
they were non-NYC residents (n=627). (See Figure 4.1 for flowchart of sample selection.) 
 
Mortality records without a location of overdose were excluded from analysis (n=344).  For this 
analysis, the outcome was limited to individuals who overdosed in the Lower East Side 
neighborhood of NYC (n=130). Location of overdose was chosen as the outcome, rather than 
location of residence or location of death, as that was the most precise location where naloxone 
could have been used to reverse the overdose.  The Lower East Side was defined as the 
aggregation of three neighborhood tabulation areas that most closely aligned with the overdose 
prevention program’s catchment area
25
: the East Village, Chinatown, and the Lower East Side.   
 
The Lower East Side Overdose Prevention Program (OPP) 
NYC’s first overdose prevention program was sited in the Lower East Side as part of a pilot 
program in June 2004.  The overdose prevention program is housed within a community-based 
non-profit harm reduction organization that primarily serves injection drug users.  Administrative 
data from the program was used to describe the number of individuals trained and the number of 
reversals reported aggregated for all years (2004-2012).  For the evaluation of effects, the 
program was treated dichotomously, with the pre-implementation phase representing years 2000-







4.2.2.  Procedures and Statistical Analysis 
Locations of the intervention, overdose deaths, and population counts were geocoded using the 
NYC Department of Health and Mental Hygiene’s geoprocessor GeoPortal.  The average annual 
overdose rate per 100,000 population for the neighborhood was calculated for the pre-
intervention phase (2000-2003) using 2000 Census population counts, and for the post-
intervention phase (2004-2012) using the 2010 Census population counts.  The rate difference 
and percent rate reduction were calculated, and the statistical significance of the difference was 
tested non-parametrically using Wilcoxon signed-rank. 
 
Street walking distance from the intervention site to each overdose location was computed using 
the ArcGIS™ 10.2 Network Analyst extension.  Street walking distance was defined as the 
shortest walkable route using city streets, and represented the most accurate measure of distance 
for individuals who access the OPP.  Mean and median distance was calculated for each phase. 
 
Overdose mortality records were divided into pre-intervention and post-intervention phases, and 
summed by census tract using geographic information software.  Census tracts were chosen 
because they were the smallest geographical unit that displayed enough detail to allow for 
comparison across groups.  Each census tract was assigned an outcome value, the number of 
heroin-related overdose deaths that occurred in that tract, and mortality rates were calculated 
using the population in each census tract. The average distance from overdose death to the 
intervention site was calculated for each census tract, as well as the distance from census tract 





To visualize trends and anomalies in the spatial distribution of the data, dot distribution maps 
were created for each year, and choropleth maps of the census tract rate of overdose fatalities 
were created for pre- and-post intervention phases, and percent rate reduction from pre- to post-
intervention.   
 
To assess overdose mortality risk as a function of distance from census tract centroid to OPP, we 
plotted the post-intervention overdose mortality rate against distance, and used Poisson 
regression to quantify the association between overdose risk and distance to intervention.  
Census tracts served as the unit of analysis, and we tested the predictor, distance from the 
intervention, as both a continuous and a categorical variable.  We used log of the 2010 census 
tract population as an offset term to account for the underlying population at risk, and determined 
that p values were significant if equal to or greater than 0.05. 
 
Analyses were performed using ArcGIS (10.2), SPSS (17.0), and SAS (9.2). 
 
4.3.  Results 
From 2004 to 2012, the LES OPP trained and dispensed naloxone to 1,239 individuals. A total of 
232 overdose reversals using naloxone were reported by the program.   
 
Between the years of 2000 and 2012, the annual number of heroin-related overdose deaths in the 
Lower East Side ranged from 4 to 14.  (See Appendix VIII for a bar chart of overdose number by 
year, and Appendix IX-XXI for dot distribution maps of overdose deaths by year.)  A total of 51 




intervention years 2000-2003 for an average annual overdose rate of 7.7 per 100,000 population, 
and 79 overdoses occurred in the post-intervention years 2004-2012, with an average annual 
overdose rate of 5.3 per 100,000 population (Table 4.1).  The overdose rate decreased by 2.3 per 
100,000 population, or 44%. 
 
Street walking distance from location of overdose to the intervention site ranged from 1,525 to 
8,921 feet.  The median distance was 5,231 feet in the pre-intervention phase and 5,283 feet in 
the post-intervention phase (mean distance was 5,092 and 5,015, respectively).  For histograms 
of distance frequencies pre- and post-intervention, see Appendix XXII and XXIII). 
 
In the pre-intervention phase, annual average overdose rates by census tract ranged from 0.0 to 
48.2 per 100,000 population.  In the post-intervention phase, rates ranged from 0.0 to 20.3. Rate 
differences between the two phases ranged from -48.2 to 14.3, with 19 of the 30 (63%) census 
tracts experiencing a decrease or no change in overdose mortality rate.  The census tract where 
the OPP was located saw the steepest decrease in heroin-related overdose deaths, from a rate of 
7.8 per 100,000 population pre-intervention to 1.31 post-intervention (rate difference=-6.5, 
percent rate reduction = -496%).  Rate differences overall for all census tracts were not 
statistically significant (Wilcoxon signed-rank p=0.150).  Maps of overdose mortality rates by 
census tract for the pre-OPP implementation period (2000-2003) and the post-implementation 





Plotting distances from the census tract centroids to the site of the intervention against census 
tract overdose mortality rates post-intervention yielded a slope with correlation coefficient 0.42 
and significance p=0.02 (Figure 4.3).   
 
Univariable Poisson regression was also used to assess the relationship between distance to the 
OPP and overdose mortality.  When distance was treated as a continuous variable, the 
association was statistically significant (p=0.0002), with each increase in foot distance 
representing an increase in risk by 0.0002.  An individual is 1.22 times more likely to die from a 
heroin overdose for every 1,000 feet away from the OPP.  When distance was treated as an 
ordinal variable with four categories, the category with the furthest distance (greater than 6,000 
feet) yielded the largest risk relative to the closest distance category (less than 3,000 feet) (3.26 
per 100,000 population, p=0.0003). 
 
4.4.  Discussion 
Using surveillance data, this population-based approach to measuring the effectiveness of 
overdose prevention programming suggests that OPPs are associated with a reduced risk of 
heroin-related overdose mortality.  The data show that heroin-related overdose mortality in 
NYC’s Lower East Side decreased by 44% after the establishment of an OPP, and the 
neighborhood immediately surrounding the OPP experienced the steepest decrease.  Mapping of 
overdose locations revealed that few overdoses occur in the immediate vicinity of the OPP.  
Regression analysis showed that, using street walking distance from overdose location to the 





These findings suggest that placement of an overdose prevention program in an urban area 
suffering from high opioid overdose mortality rates may have a protective effect on those in the 
immediate surrounding neighborhood.  They are consistent with the findings of other studies that 
have shown protective effects at the individual and population levels, and add to the literature by 
testing the intervention’s effectiveness using a novel geospatial method.  The specificity of the 
analysis, one of Bradford Hill’s causal criteria, combined with results of other studies that 
demonstrate criteria such as biological gradient, plausibility, and temporality, lends evidence that 
the association between OPPs and reduced overdose mortality may be causal.
21
   
 
This study also produces a new finding, that OPPs’ effectiveness may have spatial limits, and 
that OPPs need to be sited locally, in communities where heroin use occurs, in order to confirm a 
protective effect.   
 
There are several limitations in our analyses.  First, because of the small sample of cases in this 
geographic area, rates may be unstable.  For this reason, we combined multiple years of census 
tract data.  This, however, means that trends internal to each study period were averaged.  In fact, 
heroin-related overdose mortality decreased from 2005 to 2010 and increased from 2010 to 2012.  
These trends are obscured because the post-intervention phase is analyzed as an average across 
years. 
 
This study did not assess the role of factors other than the OPP that may have contributed to the 
decrease in heroin-related overdose mortality that was demonstrated.  It is possible that fewer 




improved in the period after 2004, or heroin purity decreased compared to the years prior.  
Furthermore, while neighborhood-level data describing the demographic profile of heroin users 
were unavailable, citywide trends, such as the aging of the population and increasing use of 
opioid analgesics and benzodiazepines, would predict an increase the rate of overdose mortality.  
We expect that outside factors such as drug use prevalence or treatment access would have had a 
similar effect on all census tracts, and therefore the associations seen were due to the OPP.  The 
fact that overdose rates decreased most substantially in the area immediately surrounding the 
OPP suggests that the program may have been responsible for at least some portion of the 
decrease in overdose mortality.  However, future analyses could introduce these factors to 
specifically evaluate their effect on the association between the OPP and overdose mortality. 
 
This study did not take into account the movement of people and drugs, using geospatial data 
such as subway lines and gang activity.  We presume that these things impact the way in which 
naloxone moves around the community.  Future analyses would include these geospatial data. 
  
While the study suggests the OPP may be associated with decreased overdose mortality at the 
ecologic level, these findings do not confirm that the same association exists at the individual 
level. For example, direct receipt of naloxone may not improve one’s chances of surviving a 
heroin-related overdose if the individuals around that person at the time of the overdose do not 
know how to use naloxone to reverse the overdose.  This study is not able to confirm that those 






This study is also unable to decipher exactly what causal pathway might explain the association.  
The program provided overdose prevention education, such as techniques to reduce overdose 
risk, and naloxone, as well as many other services geared towards the reduction of harm among 
people who use drugs.  This study is unable to differentiate between the effects of the services 
the program provided during the study period.  However, the program was established in 1992, 
and the decrease in overdose mortality did not occur until many years later, which suggests that 
the introduction of the OPP, and not other program services, may have contributed to the 
decrease. 
 
Last, we evaluated the effectiveness of OPPs using one neighborhood only, and it may be that 
characteristics unique to NYC’s Lower East Side lessen the degree to which these findings are 
generalizable to other neighborhoods and cities.  The demographic make-up of the Lower East 
Side, however, is not particularly different from the demographics of the city as a whole, so we 
suspect that the protective effects of OPPs may be replicated if studied in other contexts.  This 
study supports the findings of Walley and colleagues, which also showed an ecologic effect 
among communities in Massachusetts.
15
 It also supports the studies that have reported of OPPs at 
the individual level.   
 
To conclude, our study adds to the evidence supporting OPPs as an effective public health 
intervention, and extends these findings by suggesting the intervention, to maximize 
effectiveness, needs to be sited locally.  Because OPPs are some of the most promising 
interventions to address the growing burden of overdose mortality, they may prove a crucial 




continues to rise, both in NYC and nationally, public health agencies and community-based 
organizations in areas with high overdose mortality rates may use these findings to support the 
implementation and expansion of OPPs in order to decrease the number of lives lost to opioid 





























Number of years 4 9 
Total # of OD's 51 79 
Average annual # of OD's 12.8 8.8 
LES population estimate
1
 166,379 164,937 








For pre-intervention, population estimates come from the 2000 Census.  For post-intervention, population 
estimates come from the 2010 Census. 
 
Abbreviations: 
NYC = New York City 
OD = overdose 
LES = Lower East Side 








































Heroin ODs among NYC residents 
(n=3,906) 
ODs with toxicology positive for heroin  
(n=4,533) 
Total opioid OD deaths in study period 
(n=6,582) 
 
Exclude non-NYC residents 
(n=627) 
Exclude ODs with no heroin 
(n=2,049) 
Heroin ODs among NYC residents with 
record of OD location  
(n=3,562) 
Exclude records without a 
location of overdose  
(n=344) 
Exclude ODs that occurred 
outside of Lower East Side 
(n=3,432) 
Heroin ODs among NYC residents in 















Figure 4.3. Distance between Census Tract Centroid and Intervention Site by Census Tract 













































Chapter 5: Discussion 
 
5.1.  Overview of the Dissertation 
Heroin-related overdose in the United States (US)
1
 and New York City (NYC)
2
 represents a 
large burden of mortality, killing more individuals than traffic accidents.  Despite this, there have 
been limited studies to date to demonstrate evidence-based interventions that successfully reduce 
overdose mortality.
3
  At the individual level, cross-sectional and small cohort studies suggest that 
overdose prevention programs (OPPs) can increase individual knowledge about overdose risk 
and train people to properly administer naloxone, an opioid antagonist that reverses the effects of 
heroin overdose.  At the population level, only one study to date has demonstrated reductions in 
mortality,
4
 and none have been conducted in NYC, and which hosts one of the country’s oldest 
and largest overdose prevention programs, dispensing over 55,000 doses of naloxone.  Since the 
programs’ implementation in 2006, rates of heroin-related overdose in NYC have decreased.  
However, no studies to date have determined if the decrease in heroin-related mortality is 
associated with the implementation of NYC’s overdose prevention program. 
 
This retrospective study aimed to test for an association between New York City’s (NYC) 
overdose prevention program and heroin-related overdose mortality in NYC.  Using 13 years of 
vital statistics data matched with medical examiner records (2000-2012), representing the census 
of heroin-related overdose mortality during this time period, I used three different analytic 
approaches to identify and describe the relationship between NYC’s OPP and heroin-related 
overdose mortality.  I hypothesized that the association between the intervention and reduced 





In Chapter 2, I specifically tested the hypothesis that implementation of the OPP in 2006 reduced 
the rate of heroin-related overdose mortality, after accounting for factors other than the OPP 
that might explain temporal change in overdose mortality, between 2000 and 2012.  To do this, I 
described heroin-related overdose mortality and compared demographic characteristics of 
overdose decedents prior to OPP implementation with the demographic characteristics of 
overdose decedents post-implementation.  I then used interrupted time series analysis to compare 
the level and trend in overdose mortality before and after the introduction of the overdose 
prevention program, analyzing NYC as a whole.  I employed a negative control outcome to 
assess whether an association between the intervention and the change in level of overdose 
mortality may have been due to unmeasured confounding.   
 
In Chapter 3, I tested the hypothesis that the reduction in heroin-related overdose mortality rate 
between the seven years preceding the implementation of the OPP and the six years following its 
implementation was greater in NYC neighborhood tabulation areas in which the OPP was 
implemented, compared with neighborhood tabulation areas in which no OPP was implemented.  
I mapped overdose prevention programs using geographic information systems, and quantified 
the number of naloxone doses dispensed by neighborhood.  Use of a spatial scan statistic allowed 
me to detect geospatial clusters of heroin-related overdoses and compare neighborhoods with 
greater intervention penetration with neighborhoods with less intervention penetration to see if 
they experienced greater decreases in overdose mortality using multivariable regression.   
 
In Chapter 4, I tested the hypothesis that within the neighborhood of an OPP, risk of heroin-




zoomed in to the Lower East Side of Manhattan, used as a model, and examined overdose 
mortality risk as a function of distance from the overdose prevention program at a more granular 
level.  I calculated street walking distance from the program to each overdose mortality location. 
For each census tract, I calculated and mapped overdose mortality rates, and used Poisson 
regression to test for an association between distance from the census tract centroid and the 
number of overdose deaths per census tract.  The main findings and interpretations of each of 
these analyses are summarized in the next section. 
 
Together, these analyses, using three different statistical and geospatial techniques, help 
elucidate the relationship between NYC’s overdose prevention program and heroin-related 
overdose mortality. 
 
 5.2.  Summary of the Findings 
5.2.1.   Chapter 2 
Between years 2000 and 2012, 3,906 individuals died of heroin-related overdose in NYC.  In the 
period prior to implementation of OPP (January 2000 - June 2006), an average of 165 heroin-
related overdose deaths (age-adjusted rate (AAR) 4.9 per 100,000) occurred every six months.  
In the years after implementation (July 2006 – December 2012), 136 deaths (AAR 3.8 per 
100,000) occurred every six months on average, representing a 22% decrease in age-adjusted 
mortality rate. 
 
Interrupted time series analysis (ITS) is a method commonly used to test interventions 




implementation of the evaluation.  It allows for the comparison of levels and trends in an 
outcome, using the pre-implementation phase as a control, and has been shown to be a powerful 
analytic tool, demonstrating similar results to that of cluster-randomized controlled trials.
5
  
Because New York State passed a law allowing for OPP implementation, allowing us to see a 
clear point in time that divides pre- and post-intervention phases, and because heroin-related 
overdose mortality surveillance exist for 6.5 years prior to the law’s passage and 6.5 years after, 
ITS was an appropriate method to test the effects of the OPP intervention over time. 
 
Using segmented regression, the term representing the change in trend following implementation 
of the intervention was not statistically significant.  We therefore were able to remove this term 
from our analysis, which means we did not allow the slope to vary between implementation 
periods.  Using this form of the model, the level of heroin-related overdose mortality decreased 
by 16% following implementation of OPP.  Though this effect was not statistically significant 
(RR 0.84; CI 0.62, 1.15), the study included the universe of heroin-related overdose deaths rather 
than a sample of cases, so significance testing to determine the likelihood of a change due to 
chance is of limited interpretability.  I interpret any change in mortality to be considered a true 
change, and not one occurring due to chance. 
 
I conducted several sensitivity analyses to test the robustness of the results.  Adding three 
different covariates that may have confounded the association between the OPP and heroin-
related mortality (drug detoxification, OD prevention education, opioid-related hospitalization), 




when outliers were removed, when lag periods were introduced or when the changepoint was 
moved. 
 
I used a negative control outcome, opioid analgesic-related overdose mortality, to test whether 
the findings may have been associated not with the intervention, but with other spurious factors. 
This technique is particularly useful to detect confounding in observational studies when 
randomization is not possible.  If the OPP intervention is found to have the same effect on opioid 
analgesic-related overdose, which should be unaffected by the intervention, that would suggest 
that unmeasured confounders, not the OPP, contributed to the decrease in heroin-related 
mortality.  Using the same segmented regression model, the intervention was found to have the 
opposite effect.  Implementation of the OPP was associated with a 6% increase in opioid-related 
overdose mortality, suggesting that the intervention’s protective effects against heroin-related 
overdose were specific to the intervention and not unmeasured confounders.   
 
While a strength of ITS is its ability to compare post-intervention levels and trends using pre-
intervention levels and trends as controls, one of its limitations is that the exposure is assumed to 
be homogeneous over the post-implementation period.  In fact, in NYC, OPPs increased in 
number and size between the years 2006 and 2012.  ITS also requires many units of observation 
to be sufficiently powered.  Because this analysis only had 26 6-month periods, it may have been 
underpowered to detect a change in trend post-intervention.  Last, because this study spanned 13 
years and relied on observational data, it is difficult to identify covariate measures that are 
consistently collected over the entire study period.  As such, several covariates that ideally would 




may confound the relationship between exposure and outcome, were unable to be included in the 
analysis. 
 
My findings closely replicate the findings of a similar ITS study in Massachusetts, where an 18% 
decrease in opioid-related overdose mortality was found in communities with heavily 
implemented overdose prevention programs.
4
 Given that the ITS analysis examined NYC as a 
whole, and not merely the parts of NYC with heavily implemented OPP, I suspect that the effect 
size found was subject to dilution.  By limiting the analysis to the parts of NYC with OPP, in 
Chapter 3, I intended to get a more accurate estimate of the intervention’s effects. 
 
5.2.2.   Chapter 3 
During the years prior to OPP implementation (2000-2006), an average of 1.14 heroin-related 
OD deaths occurred in each neighborhood annually (median neighborhood OD rate per 100,000 
population over age 18 per year = 0.55).  This rate decreased to an average of 1.00 death per 
neighborhood per year in the years after implementation of the intervention (2007-2012, median 
neighborhood OD rate per 100,000 population over age 18 per year = 0.48). 
 
Measures of the locations and volume of NYC overdose prevention trainings were 
operationalized using the locations from which and the number of naloxone doses dispensed.  In 
the first six years of NYC’s OPP, 57,097 naloxone doses were dispensed.  In order to isolate 
neighborhoods with any intervention in order to more accurately measure effects, I mapped 
intervention locations and summed naloxone doses by neighborhood.   I found that one third of 




of naloxone doses dispensed per neighborhood over six years was 300 (range 0 - 6,635), or 1.33 
doses per 1,000 neighborhood population over age 18 per year.   
 
Spatial scans, a method that detects potential clusters where risk is elevated relative to 
everywhere in NYC outside of the cluster, detected three statistically significant clusters of 
heroin-related ODs prior to OPP: South Bronx/Northern Manhattan, Central and Downtown 
Brooklyn/Lower East Side Manhattan, and East Brooklyn.  After implementation of OPP, three 
significant clusters remained but clusters decreased in geographic size, suggesting fewer areas 
with heightened risk:  South Bronx, Lower East Side Manhattan, and Central Brooklyn.  Cluster 
relative risk in the neighborhood with minimal naloxone coverage (Central Brooklyn), where we 
would not expect to see a reduction in overdose risk, did not change: risk of overdose mortality 
in this area was similar in the pre-OPP period to that of the post-OPP period.   
 
I categorized neighborhoods into four strata based on the total number of naloxone doses 
dispensed in that neighborhood per neighborhood resident: no naloxone, low naloxone 
penetration (<5.1 doses per 1,000 residents), medium naloxone penetration (6.8 to 20.2 doses per 
1,000 residents), and high naloxone penetration (>21.9 doses per 1,000 residents).  Examining 
overdose mortality revealed that all strata experienced decreases in OD mortality from pre-OPP 
to post-OPP.  High naloxone penetration neighborhoods experienced the largest rate decrease 
(rate difference = -0.8 in no naloxone neighborhoods, -0.7 in low penetration neighborhoods,      
-1.6 in medium penetration neighborhoods, and -3.1 in high penetration neighborhoods).  
Neighborhoods with no naloxone experienced a decrease in OD mortality similar to that of 




and no naloxone neighborhoods was statistically significant (p=0.0007) after controlling for 
neighborhood population density.  Other neighborhood characteristics (age, gender, race, 
household composition) were not significantly associated with overdose mortality rate difference. 
 
I conducted sensitivity analyses to test whether the large amount of neighborhoods with no 
naloxone had impacted the outcome.  Limiting the analysis to only those neighborhoods with any 
naloxone distribution and treating the predictor as a continuous variable confirmed the findings.  
The rate of naloxone doses dispensed per neighborhood population was statistically significantly 
associated with overdose mortality rate difference after controlling for population density 
(p=0.0003).  For every increase of 10 naloxone doses per 1,000 population, we would expect to 
see 2.6 overdose deaths averted.   
 
A major strength of this analysis is in its rich overdose surveillance database, which enables 
mapping of overdose locations within neighborhoods and allows for neighborhood comparisons.  
This database also allows us to limit the analysis to only those overdoses in which toxicologies 
were positive for heroin, as heroin users and their social networks were the primary target for 
OPPs.  A limitation of this method, however, is that we do not know if the neighborhoods where 
naloxone was dispensed are the same neighborhoods where naloxone is used.  Because 
neighborhoods are all located within a relatively small geographic area, and NYC has an 
accessible public transit system, diffusion of the intervention may have occurred.  This could 
have contributed to the decrease in overdose mortality found in the neighborhoods with no 
naloxone dispensing locations.  Another limitation of this analysis is that while the exposure was 




naloxone.  This analysis is unable to disentangle whether the effects of naloxone from those of 
overdose prevention education.   Last, this study takes place at the neighborhood level only.  It 
cannot determine if individuals who receive overdose prevention training and naloxone 
personally experience protective effects, or if this finding is solely ecologic.  To answer this 
question, hierarchical linear modeling would be ideal.  However, data on naloxone use at the 
individual and neighborhood level was unavailable, so this method was not possible. 
 
5.2.3.   Chapter 4 
In the Lower East Side Manhattan, which hosted NYC’s first OPP, an average of 12.75 heroin-
related overdose deaths occurred annually in the years prior to the implementation of OPP (2000-
2003) and 8.78 deaths in the years after implementation of OPP (2004-2012).  Average annual 
rate per 100,000 population decreased by 30.6%, from 7.66 to 5.32. 
 
Using a method that has been applied to evaluate a safer injection facility in Vancouver, 
Canada,
6
 I tested the hypothesis that mortality risk increases as distance from the intervention 
increases.  This rationale derives from Bradford Hill’s causal criterion of specificity, which states 
that a causal association is more likely if the association is at a specific site among a specific 
population.
7
 If the OPP did in fact exhibit a protective effect, we would assume that distance 
from the OPP to the location of OD mortalities would increase after implementation of the OPP.  
In fact, median street walking distance from overdose location to OPP was slightly larger after 
implementation of the LES OPP, 5,231 feet in the pre-intervention period compared to 5,283 feet 





Nearly two thirds of census tracts (63%) in the Lower East Side saw a decrease or no change in 
overdose mortality from pre-OPP to post-OPP period, with rate differences ranging from -48.2 to 
14.3 per 100,000 population.  The census tract where the OPP was located experienced the 
greatest decrease in heroin-related overdose death, from 7.8 per 100,000 in the pre-OPP period to 
1.31 in the post-OPP period (rate difference -6.5, percent rate reduction -496%).  Census tract 
overdose mortality rate in the post-OPP period was correlated with distance from the OPP, and 
this correlation was statistically significant (r=0.42, p=0.02). Univariable regression analysis 
showed that distance from the intervention, measured both as a continuous and a categorical 
variable, was significantly associated with overdose mortality risk.  When distance was treated as 
a continuous variable, each increase in foot distance represented an increase in risk by 0.0002 
(p=0.0002).  An individual is 1.22 times more likely to die from a heroin overdose for every 
1,000 feet away from the OPP.  When distance was treated as an ordinal variable with four 
categories, the category with the furthest distance (greater than 6,000 feet) yielded the largest 
risk relative to the closest distance category (less than 3,000 feet) (3.26 per 100,000 population, 
p=0.0003). 
 
The important contribution of this analysis is its suggestion that OPPs’ effectiveness may have 
spatial boundaries.  In order to maximize their protective effects, OPPs need to be sited locally.  
A limitation of this study was its small sample of cases, which necessitated the aggregating of 
multiple years of census tract data.  As such, trends internal to each period were averaged, 
obscuring the fact that, in the post-OPP period, rates decreased from 2006 to 2010 and then 
increased from 2010 to 2012.  Similar to the analyses in Chapter 3, this chapter is also limited by 




and is also only able to show ecologic effects, which again may not represent an association at 
the individual level.  This is the first study of its kind to measure the link between overdose risk 
and distance to OPP.  In order to better understand this relationship, the method would need to be 
repeated in other neighborhoods.    
 
5.3.  Strengths and Public Health Significance 
This study has a number of strengths.  The study sample, using data from the NYC Office of the 
Chief Medical Examiner, which is responsible for investigating all deaths of a suspicious nature, 
comprises a near census of heroin-related overdose deaths among NYC residents during the 
study time period.
8
 In-depth toxicology results allows for the restriction of the sample to those 
overdoses positive for heroin use, which is the specific population targeted by the OPP 
intervention.  The large sample size, nearly 4,000 individuals, enables stratification by year and 
by neighborhood in order to isolate and identify patterns.   By studying 13 years of data, 
conclusions regarding differences between pre-OPP and post-OPP periods are relatively stable 
and less suspect to chance fluctuations in the data which occur year to year.   
  
A key methodological strength to this study is its use of multiple innovative approaches to test 
for population-level effects of the overdose prevention program.  Using interrupted time series 
allows for the assessment of the intervention’s effects on the level and trend of the outcome, 
controlling for other time-varying trends that occurred in NYC during the study period, namely 
the decrease in detoxification admissions and the increase in opioid use, as measured by opioid-
related hospitalizations.  This method, using pre-intervention data as controls, has been found to 
be comparable to measures of cluster-randomized, controlled trials.
9




methods, this study is able to assess the effects of the intervention at a more granular level, first 
by comparing neighborhoods within NYC, and then by comparing census tracts within one 
neighborhood.  Spatial covariate information was included in order to account for neighborhood-
level differences that may explain an association between the intervention and any reduction in 
heroin-related overdose mortality.  
 
By triangulating findings from both time series and geospatial methods, a case can be made for 
the protective effects of the OPP. While the findings from time series analyses were not 
statistically significant, they did show an association in the direction of a protective effect.  This 
analysis evaluated the city as a whole, and Chapter 3 found that the majority of NYC 
neighborhoods hosted no intervention, suggesting that time series analysis repeated just among 
neighborhoods with the intervention, may reach statistical significance.  These findings, in 
conjunction with two geospatial methods finding positive associations, suggest that the 
association between the intervention and heroin-related overdose mortality is likely not due to 
chance.  While this association, which uses observational data only, cannot be interpreted as a 
causal relationship, these findings, in conjunction with findings from other studies, may together 
contribute to a building body of literature suggesting the association is causal. 
 
This is the first study to demonstrate effects of NYC’s overdose prevention program, and only 
the second in the country to demonstrate population-level effects of the intervention more 
generally.  This study reproduces the findings of a similar interrupted time series conducted in 
Massachusetts, and adds to it by introducing novel methods that confirm the associations 




A final strength of this study is its relevance and timeliness amidst a growing opioid overdose 
epidemic, both in NYC and across the US.  Increasing resources and attention are turned to 
identifying evidence-based interventions that cities and states can implement to address the 
morbidity and mortality associated with opioid use.  This study’s findings can be a useful 
contribution as jurisdictions decide which interventions to implement, where to target them, and 
how to allocate resources in the most cost-effective manner.   
 
5.4.  Limitations 
This study used observational data and was not subject to the rigors of a randomized, controlled 
environment, and as such, it is subject to several limitations.  As such, I cannot assert that the 
associations described here are causal effects, because I cannot guarantee that they are unaffected 
by unmeasured confounding.  The overdose prevention program is a two-part intervention which 
always included training on overdose risk reduction as well as naloxone dispensing.  Because the 
two components were never administered separately and could not be measured separately, the 
effects that were found could have been attributed to either or both of the intervention 
components.  This suggests that overdose prevention programs, in order to maximize the chance 
of impacting overdose mortality, should continue to offer the pairing of risk reduction education 
with naloxone, until further evidence is available.  Second, data on the number of naloxone doses 
directly dispensed to individuals were unavailable, so the number of doses provided to OPPs was 
used as a proxy measure (in Chapter 3) of the intervention.  It is assumed that OPPs do not 
dispense 100% of their naloxone supply, and thus, measurement of the intervention’s magnitude 
was likely to be over-estimated.  Accordingly, any findings are conservative, and likely due to 




location in which naloxone doses were dispensed, though they could have been utilized in other 
locations (in Chapters 3 and 4).  (Data on location of naloxone utilization was unavailable.)  This 
could have violated the Stable Unit Treatment Value Assumption, which assumes that the effect 
of the exposure on one neighborhood is independent of the exposure on other neighborhoods.
10
 If 
this assumption were violated, intervention dissemination would have presumably misclassified 
naloxone doses from areas of higher penetration to areas of lower penetration, resulting in a 
conservative effect estimate, biasing findings towards the null.  Fourth, for all analyses the 
intervention was evaluated dichotomously (pre versus post), which does not allow for variation 
in the amount the intervention was implemented over time.  In fact, OPPs began in 2006 and 
have slowly increased in number and reach over time.  By averaging intervention effects across 
years, variation over time is lost.   
 
Because this intervention was not randomly assigned, we cannot assume that units of analysis 
(years, neighborhoods, census tracts) are exchangeable, meaning one unit would have had equal 
risk of overdose mortality, had OPP not been implemented.
11 
Because areas with higher overdose 
mortality burdens were in fact targeted for the intervention, this assumption was violated.  In 
order to account for these differences, covariates were introduced into multivariable models 
(time-varying covariates in Chapter 2, neighborhood-varying characteristics in Chapter 3), but 
residual, unmeasured confounding could have remained.  Ideally, prevalence of heroin use could 
be controlled for over time and at the neighborhood-level, but measures were unavailable.  A 
proxy, opioid-related hospitalizations, was available and used at the city level in Chapter 2, but 
could have been an incomplete proxy.  Additionally, this variable was unavailable for units of 




by neighborhood, such as polydrug use, substance use treatment access, and poverty, if available 
at the neighborhood level, would have improved the rigor of these analyses.   
 
Last, all findings are applicable at the ecologic level only. Results found at the ecologic level 
cannot be interpreted to apply at the individual level.  It could be that individuals directly trained 
in overdose prevention and who receive naloxone may not themselves experience the protective 
effects of the intervention, but those around them do.  However, when an exposure affects many 
individuals simultaneously, ecologic designs such as those that study neighborhood effects, are 
often better equipped to answer a research question than individual-level designs.
12
   Analytic 
techniques that take advantage of multiple levels of data, including both individual and 
neighborhood levels such as hierarchical linear models, were not possible because joint 
distributions of individual and neighborhood-level data was unavailable.   
 
5.5.  Policy Recommendations and Future Research Directions 
Findings from this study will allow jurisdictions to calculate the number of naloxone doses need 
to effectively curtail the heroin-related overdose burden, a calculation that could not have been 
done previously. 
 
The effectiveness of this intervention suggests that expanded access to OPP for heroin users and 
those at risk of witnessing heroin overdose could further reduce overdose mortality.  While this 
study’s findings do not suggest particular means of increasing access, policymakers have 
suggested that access to naloxone could be expanded through a number of strategies, using both 




(1) OPPs need to be offered to individuals with minimal barriers in a low-threshold 
manner, requiring little time, no or minimal identifying personal information, and no 
qualifications or certifications.  A recent study has shown that brief education, as short as five to 
10 minutes, can achieve a high level of knowledge, comfort, and facility managing opioid 
overdose.
13
   
(2) Policies that enable OPPs to dispense naloxone in wider areas at more hours of the 
day and night should be implemented.  These include naloxone access laws; third party 
prescribing laws, which allow third parties, not solely those at risk of overdose themselves but 
those who may witness opioid overdose, to receive a prescription for naloxone with the intent for 
community-based, pre-hospital administration; non-patient specific prescriptions, or “standing 
orders,” which allow non-clinically trained personnel to dispense naloxone under a medical 
director’s license; and prescriber liability protections, which protect those who prescribe, 
dispense, or distribute naloxone to laypersons from criminal prosecution.
14
 
(3) For those who could benefit from naloxone but are not able to or do not choose to 
access overdose prevention programs, naloxone needs to be more widely available in traditional 
clinical settings such as primary care clinics, emergency departments, and pharmacies.  
Physician and pharmacist education needs to be developed and implemented more widely, 
naloxone needs to be covered by both public and commercial insurance carriers, and/or naloxone 
could be available over-the-counter at pharmacies.   
(4) At this time, naloxone is available in three formulations.  Two of these require 
somewhat complicated assembly.  (The third formulation, an auto-injector, is new to the market, 
has limited availability, and is nearly ten times as costly as the other formulations.)  In order to 




little training, are easy to carry with a person at all times, and are affordable.  At this time, a few 
products are undergoing clinical trial, but are not yet available, with the exception of the auto-
injector, Evzio.
©
   
 
Future analyses could test the hypotheses that, by expanding access to naloxone through the 
programmatic and policy initiatives above, opioid overdose mortality rates will further decrease. 
 
Because this study is the first of its kind, future research is needed to replicate, confirm, and 
better understand the findings described here.  Specifically, analyses that utilize interrupted time 
series at the neighborhood level, analyzing only those neighborhoods which hosted OPP 
dispensing sites, could be an important contribution.  Similarly, sensitivity analyses that repeat 
the ITS but use other statistical methods, such as ARIMA models, could confirm the findings in 
Chapter 2.  Other types of time series methods that analyze trends year-by-year, such as linear or 
joinpoint regression or age-period-cohort modeling, could supplement the comparison of two 
periods conducted in Chapter 2.  Year-by-year analyses such as these could help us better 
understand the association between OPPs and overdose mortality, particularly since a limitation 
of the post-OPP period in my study its lack of homogeneity with respect to the exposure, and 
overdose mortality rates decreased and then increased within the span of the period.   
 
In order to confirm the findings described in Chapter 3, neighborhood-level analyses could be 
replicated using a different geographic area, such as community districts, United Hospital Fund 
neighborhoods, or police precincts, to determine if the finding is specific to the definition of the 




The distance analysis performed in the Lower East Side of Manhattan in Chapter 4 could be 
replicated in other neighborhoods that similarly have one fairly strong OPP, in order to 
determine if the correlation between distance and overdose risk is particular to the LES OPP or 
generalizable to other OPPs.  Washington Heights, in northern Manhattan, is one such 
neighborhood that has hosted a strong OPP and kept rigorous records, and may be a good 
candidate for future research. 
 
This study only analyzed heroin-related overdoses, as that was the community of individuals 
targeted by OPPs in NYC originally.  However, overdoses involving opioid analgesics make up 
an increasing proportion of all overdose deaths.  It is unknown to what degree this initiative may 
reduce opioid analgesic-related overdose mortality at the population level.  Because it is 
physiologically similar to heroin, the effects of opioid analgesics can similarly be reversed with 
naloxone, but because use patterns may be different, it is unknown if the intervention would be 
equally effective.  For example, the effectiveness of naloxone relies on the presence of a witness 
to the overdose victim who can administer naloxone.  No research to date has determined if 
opioid analgesic overdoses occur in the presence of others to the same extent that heroin 
overdoses do.  Repeating the analyses described here, focusing on opioid analgesic-related 
overdose, would be a particularly valuable contribution to the literature. 
 
This study evaluated the overdose prevention program primarily using neighborhoods as the unit 
of analysis.  In effect, I tested the theory of neighborhood effects:  can an entire neighborhood 





The theory of neighborhood effects is premised on the recognition that “social influences on 
health operate through many different processes, one of which may be the types of areas or 
neighborhoods in which people live.”
15
 Neighborhoods and their contexts can be both pathogenic 
and salutogenic, putting residents at risk of morbidity and mortality while also affording 
residents health-promoting opportunities.   
 
By focusing on neighborhoods, we assume that regardless of whether or not an individual has 
been trained in overdose prevention, that individual enjoys the protective effects if he or she lives 
in a neighborhood in which others have been trained.   
 
This is the first time that the theory of neighborhood effects has been tested using the NYC 
overdose prevention program.  The findings here suggest that interventions that are delivered to a 
relatively small number of individuals can have important effects on population health.  High 
naloxone penetration neighborhoods had as few as 11 individuals trained per 1,000 residents, yet 
saw a 33% decrease in overdose mortality rate from pre-OPP to post-OPP.   
 
The idea that neighborhoods can provide health conferring effects on the individuals that live in 
them, and that interventions that improve neighborhoods may not need to be large, expensive, or 
far-reaching, has important implications.   
 
This study demonstrates a framework for using extant, observational data to assess the impact of 
health interventions in the real world, where randomized treatment assignment is often not 




understand if and how our programs and policies are impacting the populations they affect.  
What are the methods we can use, given imperfect measures, to try and understand what 
interventions work?  In many situations in public health, we are “stuck with observational [data] 
to answer causal questions.”
16
   
 
In this study, I used OPPs to test this framework – namely, by combining several methods, both 
temporal and spatial, of analyzing the effects of an intervention to try and infer causal effects.  A 
similar framework could be applied to other community-based interventions where the impact on 
population health is unknown.  This framework, which builds on methods such as directed 
acyclic graphs, instrumental variables, and propensity score matching, can add to the toolbox of 








Appendix I.   Timeline of Key Policy Events Related to Overdose Mortality, New York City, 2000-2012
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Appendix II. Interrupted Time Series Models using Segmented Negative Binomial (NB) 
Regression 
 
Saturated segmented NB regression model: 
𝐿𝑜𝑔(𝐸(𝑌)) =  𝛽0 +  𝛽1𝑇𝑖𝑚𝑒 +  𝛽2𝑂𝑃𝑃𝑖 + 𝛽3𝑇𝑖𝑚𝑒𝑃𝑜𝑠𝑡𝑂𝑃𝑃𝑖 +  log (𝑝𝑜𝑝𝑢𝑙𝑎𝑡𝑖𝑜𝑛) 
 
Y is the independent outcome variable (number of unintentional heroin-related overdoses 
aggregated into 6-month periods). Linear trends over the study period were accounted for by 
using a time variable, expressed as one for January 1 through June 30, 2000 and increasing in 
integer increments for each period; 𝛽1is the model coefficient for the semiannual Time variable.   
The changepoint, introduction of OPP, was accounted for by using a dummy variable, OPP, 
expressed as zero for each six-month period from January 1, 2000 through June 30, 2006, and as 
one for each six-month period from July 1, 2006 through December 31, 2012. 𝛽2 is the 
coefficient for the indicator variable for the implementation of OPP.  𝛽3is the model coefficient 
for the 6-month time periods following implementation of OPP, with all periods prior to 
implementation coded as zero, and starting with one for the first period of implementation (July 
1- December 31, 2006) and increasing in integer increments for each period.   𝛽𝑘 represents the 
effects for a set of covariates of interest (opioid-related hospitalizations (Hosp), drug 
detoxification (Detox), and overdose prevention education (ODEduc)).   
 
 
Final segmented NB regression model 
𝐿𝑜𝑔(𝐸(𝑌)) =  𝛽0 +  𝛽1𝑇𝑖𝑚𝑒 +  𝛽2𝑂𝑃𝑃𝑖 +  log (𝑝𝑜𝑝𝑢𝑙𝑎𝑡𝑖𝑜𝑛) 
 
 
Sensitivity analysis 1:  Segmented NB regression model adjusting for detoxification 
𝐿𝑜𝑔(𝐸(𝑌)) =  𝛽0 +  𝛽1𝑇𝑖𝑚𝑒 + 𝛽2𝑂𝑃𝑃𝑖 + 𝛽3𝐷𝑒𝑡𝑜𝑥𝑖 + log (𝑝𝑜𝑝𝑢𝑙𝑎𝑡𝑖𝑜𝑛) 
 
 
Sensitivity analysis 2:  Segmented NB regression model adjusting for syringe exchange (proxy 
for OD prevention education) 
𝐿𝑜𝑔(𝐸(𝑌)) =  𝛽0 +  𝛽1𝑇𝑖𝑚𝑒 +  𝛽2𝑂𝑃𝑃𝑖 + 𝛽3𝑂𝐷 𝑝𝑟𝑒𝑣𝑒𝑛𝑡𝑖𝑜𝑛 𝑒𝑑𝑢𝑐𝑎𝑡𝑖𝑜𝑛𝑖 +  log (𝑝𝑜𝑝𝑢𝑙𝑎𝑡𝑖𝑜𝑛) 
 
 
Sensitivity analysis 3:  Segmented NB regression model adjusting for opioid-related 
hospitalization (proxy for prevalence of opioid use) 





Appendix III. Time Plot of Unique Number of Individuals with Living with HIV/AIDS and in 
Medication Assisted Treatment by Year, New York City, 2000-2012 
 
 





















































Appendix IV.  Time Plot of Unique Number of Individuals in Detoxification, Syringe Exchange, 





























































































































































































Appendix V.  Maps of Heroin-related Overdose Mortality by Neighborhood, NYC, 2000-2012 
 


















Appendix VI.  Overdose Mortality Cluster Detection, NYC, Pre- and Post-Implementation of 








Appendix VII.  Specification of Multivariable Models 
𝑂𝑣𝑒𝑟𝑑𝑜𝑠𝑒 𝑟𝑎𝑡𝑒 𝑑𝑖𝑓𝑓𝑒𝑟𝑒𝑛𝑐𝑒
=  𝛽0 +  𝛽1(log 𝑑𝑜𝑠𝑒 𝑟𝑎𝑡𝑒𝑙𝑜𝑤) + 𝛽2(log 𝑑𝑜𝑠𝑒 𝑟𝑎𝑡𝑒𝑚𝑒𝑑𝑖𝑢𝑚)
+  𝛽3(log 𝑑𝑜𝑠𝑒 𝑟𝑎𝑡𝑒ℎ𝑖𝑔ℎ)  +  𝛽4(𝑝𝑜𝑝𝑢𝑙𝑎𝑡𝑖𝑜𝑛 𝑑𝑒𝑛𝑠𝑖𝑡𝑦) + 𝑒 
 














































































































































































Appendix XXII. Histogram of Frequency of Overdose Deaths by Street Walking Distance from 

















































Appendix XXIII. Histogram of Frequency of Overdose Deaths by Street Walking Distance from 



















































Appendix XXIV.  List of Abbreviations 
AAR = age-adjusted rate 
AIDS = acquired immunodeficiency syndrome 
CBO = community-based organization 
CI = confidence interval 
Detox = detoxification 
DOHMH = Department of Health and Mental Hygiene 
ESDA = exploratory spatial data analysis 
FDA = Food and Drug Administration 
Ft = feet 
HCV = hepatitis C virus 
HIV = human immunodeficiency virus 
ICD = International Classification of Diseases 
ITS = interrupted time series 
LES = Lower East Side 
LESHRC = Lower East Side Harm Reduction Center 
MAT = medication assisted treatment 
Max = maximum 
Min = minimum 
N/A = not applicable 
NTA = neighborhood tabulation area 
NYC = New York City 
NYS = New York State 
OD = overdose 
ONDCP = Office of National Drug Control Policy 
OPP = overdose prevention program 
Pop = population 
RR = risk ratio 
SE = standard error 
SES = socioeconomic status 
SPARCS = Statewide Planning and Research Cooperative System 
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